data_2lrd_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrd _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.783 HD13 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 32' ' ' VAL . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HD13 ' A' ' 17' ' ' ILE . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.59 ' N ' HG21 ' A' ' 21' ' ' VAL . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.682 HD13 HG13 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.61 ' O ' HG11 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.077 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.505 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 28' ' ' ASP . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.632 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 1.043 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.077 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.688 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.461 ' CD ' ' HZ3' ' A' ' 10' ' ' LYS . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.544 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.406 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.952 HG12 HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.871 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.736 ' HB3' HG21 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.952 HD12 HG12 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.444 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.688 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.52 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.612 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.612 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.767 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 1.027 HG11 HG13 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.421 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.706 ' O ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.041 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 1.023 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 1.027 HG13 HG11 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.699 HD12 HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.041 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 1.018 ' HB3' HD23 ' A' ' 60' ' ' LEU . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.604 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.743 ' HD1' HD11 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.722 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.023 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.744 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 54' ' ' VAL . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.018 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.555 ' N ' HD22 ' A' ' 60' ' ' LEU . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.558 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.441 ' N ' HG13 ' A' ' 11' ' ' VAL . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.63 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 27' ' ' ILE . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.531 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.772 ' HA ' HG11 ' A' ' 21' ' ' VAL . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.595 ' O ' HG12 ' A' ' 32' ' ' VAL . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.032 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.826 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 28' ' ' ASP . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.791 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.618 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 46' ' ' PHE . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.032 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.611 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 1.5 m170 -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.001 HG12 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.994 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.001 HD13 HG12 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.702 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.702 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.676 HD13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 27' ' ' ILE . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 18' ' ' ALA . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 21' ' ' VAL . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.063 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.6 HG23 ' CG1' ' A' ' 17' ' ' ILE . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.767 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.767 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.063 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.909 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.82 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.675 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.114 HG12 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.114 HD13 HG12 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 122.414 1.102 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.605 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 9' ' ' LYS . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.605 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 27' ' ' ILE . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.076 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.747 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.801 HG22 HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.95 HD12 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.714 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 36' ' ' LEU . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.903 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.076 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.773 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.719 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.749 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.753 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.95 ' HG ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.903 HD23 ' HB3' ' A' ' 43' ' ' ALA . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.437 ' H ' HG21 ' A' ' 7' ' ' VAL . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.534 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.693 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 9' ' ' LYS . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.785 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.803 HD12 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.803 HG13 HD12 ' A' ' 17' ' ' ILE . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.4 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 27' ' ' ILE . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.033 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.711 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.765 ' CG1' HG11 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.977 HD22 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.033 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.418 ' CB ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' A' ' 29' ' ' LEU . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.624 HD22 HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.697 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.697 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.666 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.739 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 27' ' ' ILE . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.64 ' HA ' HG12 ' A' ' 21' ' ' VAL . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.619 ' O ' HG11 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.013 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD3' HG13 ' A' ' 54' ' ' VAL . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.097 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.874 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.883 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.013 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.952 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.1 p80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' HD3' ' A' ' 30' ' ' PRO . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.658 ' HA ' HD13 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' CB ' HG23 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.097 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.524 ' O ' HD21 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.0 tptm . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.637 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.637 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.792 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.764 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.646 HD12 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 HG12 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 21' ' ' VAL . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 27' ' ' ILE . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.039 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.692 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.775 HG12 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.836 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.039 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.815 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' A' ' 44' ' ' SER . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.72 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.658 ' O ' HD11 ' A' ' 58' ' ' LEU . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 1.084 ' HA ' HD23 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.403 ' HB3' ' CG2' ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.084 HD23 ' HA ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.552 ' O ' HD22 ' A' ' 60' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 tptt . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.693 ' H ' HG11 ' A' ' 7' ' ' VAL . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.806 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.92 HD12 HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 17' ' ' ILE . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.762 HD12 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.686 ' O ' HG11 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.035 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.875 ' HB3' HG22 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.737 ' CG1' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.035 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.562 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.931 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.711 ' HB3' HG21 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.518 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HZ2' ' HG2' ' A' ' 40' ' ' GLU . 22.4 tptm . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.808 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.626 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.609 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.626 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.648 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.614 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.733 HG11 ' CG1' ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.481 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.667 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.013 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.733 ' CG1' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.79 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.691 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' HZ2' ' A' ' 4' ' ' LYS . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.902 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.808 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.013 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.662 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.662 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.865 HG12 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.595 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.834 HD11 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.676 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.676 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.747 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 27' ' ' ILE . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.617 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.041 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 28' ' ' ASP . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.819 HD23 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.819 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.678 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.041 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.797 ' HB3' HD23 ' A' ' 60' ' ' LEU . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.492 ' CE1' HG22 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.603 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HB3' HG23 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.732 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 17' ' ' ILE . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 27' ' ' ILE . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.914 ' HB3' HG12 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.622 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.889 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.684 ' CB ' HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.472 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 30' ' ' PRO . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HA ' HD22 ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.909 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.654 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CB ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.481 ' H ' HG12 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.561 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 27' ' ' ILE . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.625 ' HA ' HG12 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.648 ' O ' HG12 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.077 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.934 HD23 ' HG2' ' A' ' 37' ' ' LYS . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.934 ' HG2' HD23 ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.742 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.503 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.077 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.626 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.626 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.626 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HD3' ' A' ' 30' ' ' PRO . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.854 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.052 HD22 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.513 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.052 ' HG ' HD22 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 tttp . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.726 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.481 ' H ' HG11 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.726 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.988 HG12 HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 1.001 HG11 HG12 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.663 ' N ' HG22 ' A' ' 21' ' ' VAL . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.71 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.86 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG12 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.63 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 1.001 HG12 HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.988 HD21 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.707 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.623 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.86 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.88 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.536 ' ND1' HD13 ' A' ' 29' ' ' LEU . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.88 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.897 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.864 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' CB ' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.483 ' HB3' HD22 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.515 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.611 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.95 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 17' ' ' ILE . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.67 ' HA ' HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.576 ' O ' HG12 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.097 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HD2' ' C ' ' A' ' 28' ' ' ASP . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 17' ' ' ILE . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.946 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.95 HD22 ' HB ' ' A' ' 17' ' ' ILE . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.619 ' CB ' HD13 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.934 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.713 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.844 ' HB3' HD13 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.646 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.435 ' O ' HD11 ' A' ' 58' ' ' LEU . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.744 ' HA ' HD22 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HG ' HD23 ' A' ' 58' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.611 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.597 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.611 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.771 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.688 HG12 HD12 ' A' ' 17' ' ' ILE . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.629 ' HA ' HG13 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.057 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.789 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 60' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.057 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 1.066 ' HB3' HD21 ' A' ' 60' ' ' LEU . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.839 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 30' ' ' PRO . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.541 ' CB ' HG23 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 55' ' ' CYS . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.066 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.512 ' C ' HG12 ' A' ' 7' ' ' VAL . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.512 HG12 ' C ' ' A' ' 6' ' ' SER . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.56 ' HG3' HD11 ' A' ' 8' ' ' LEU . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.621 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.627 HG11 ' CD1' ' A' ' 17' ' ' ILE . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.6 HD13 HG13 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.718 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.02 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.899 HG23 HD13 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.582 HD23 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.481 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.831 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 1.114 ' HB3' HD22 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HD1' HD11 ' A' ' 29' ' ' LEU . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.822 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 1.114 HD22 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.525 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD21 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.609 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.798 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.886 HD12 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.886 ' HB1' HD12 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.835 HG13 HG13 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.941 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HB3' HG13 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.835 HG13 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.861 HD23 ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.79 ' CD2' HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.714 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.699 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.941 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.699 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.77 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.831 ' HA ' HD22 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HG2' ' HZ2' ' A' ' 56' ' ' LYS . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.916 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.916 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.617 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.405 ' H ' HG11 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.876 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.769 HD13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 27' ' ' ILE . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.557 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.049 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.651 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.762 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.78 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.762 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.678 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.049 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.869 ' HB3' HD23 ' A' ' 60' ' ' LEU . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.728 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.529 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.66 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 1.04 HG12 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.772 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG12 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.665 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.79 HG11 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.79 ' H ' HG11 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.665 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.943 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.772 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' ILE . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 1.079 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.862 ' CG2' HD13 ' A' ' 17' ' ' ILE . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 1.108 HD13 ' HG ' ' A' ' 58' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.943 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' CB ' HD23 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 1.079 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.697 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . 0.697 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.5 p80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.69 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.56 HG13 ' HG ' ' A' ' 29' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HA ' HD22 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 1.108 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.6 m170 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HG ' ' CD2' ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.819 ' H1 ' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.6 ttt -57.21 -56.82 16.82 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.633 0.583 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 87.38 -168.55 38.54 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.2 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt -84.11 36.98 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.679 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.783 HD13 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' O ' ' HB1' ' A' ' 22' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB1' ' HB ' ' A' ' 32' ' ' VAL . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.783 HG11 HD13 ' A' ' 17' ' ' ILE . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.59 ' N ' HG21 ' A' ' 21' ' ' VAL . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.4 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.682 HD13 HG13 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.61 ' O ' HG11 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.077 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.505 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.61 HG11 ' O ' ' A' ' 28' ' ' ASP . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.632 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 1.043 HD22 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.632 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 1.043 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.679 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.077 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.688 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.819 ' HG3' ' H1 ' ' A' ' 1' ' ' ALA . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 6.9 m170 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.544 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.406 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.406 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.952 HG12 HD12 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.871 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.736 ' HB3' HG21 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.952 HD12 HG12 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.444 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.688 ' CD1' ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.525 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 7.5 ptp -119.16 122.32 41.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.934 0.397 . . . . 0.0 111.385 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 63.96 -152.2 48.89 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.514 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? -80.37 28.99 0.3 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' H ' ' C ' ' A' ' 3' ' ' GLY . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.612 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.4 ' CG1' ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.4 ' H ' ' CG1' ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.612 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.464 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.464 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.767 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HB2' ' HA ' ' A' ' 13' ' ' CYS . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.821 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.767 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 1.027 HG11 HG13 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.421 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.773 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.535 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.706 ' O ' HG11 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.041 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 1.023 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 1.027 HG13 HG11 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.699 HD12 HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.663 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.675 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.663 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.604 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.52 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.041 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 1.018 ' HB3' HD23 ' A' ' 60' ' ' LEU . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.604 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.743 ' HD1' HD11 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.722 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.023 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.744 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.758 ' HB3' HG21 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.928 HD12 HG12 ' A' ' 54' ' ' VAL . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.702 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.018 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.555 ' N ' HD22 ' A' ' 60' ' ' LEU . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.564 0.221 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.1 ptm -106.02 100.98 10.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.264 0.554 . . . . 0.0 111.273 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.551 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 82.92 165.83 38.18 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.323 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm -81.68 31.46 0.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.939 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.558 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.441 ' N ' HG13 ' A' ' 11' ' ' VAL . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.762 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.63 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.762 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.772 HG11 ' HA ' ' A' ' 27' ' ' ILE . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.531 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.772 ' HA ' HG11 ' A' ' 21' ' ' VAL . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.595 ' O ' HG12 ' A' ' 32' ' ' VAL . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.032 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.826 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.595 HG12 ' O ' ' A' ' 28' ' ' ASP . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.791 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.648 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.791 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 36' ' ' LEU . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.618 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.675 ' O ' ' HB3' ' A' ' 46' ' ' PHE . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.939 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.032 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.519 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.611 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.413 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 1.5 m170 -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.001 HG12 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.855 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.409 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.994 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.001 HD13 HG12 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.519 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.273 0.083 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.3 mtt 68.39 -75.62 0.06 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.852 0.72 . . . . 0.0 112.64 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 97.84 -153.53 20.11 Favored Glycine 0 CA--C 1.492 -1.399 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -85.01 30.75 0.57 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.702 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.702 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.777 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.676 HD13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.777 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.472 ' HB2' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.744 HG12 ' HA ' ' A' ' 27' ' ' ILE . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.543 ' HB1' ' O ' ' A' ' 18' ' ' ALA . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.744 ' HA ' HG12 ' A' ' 21' ' ' VAL . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.063 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.708 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.517 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.6 HG23 ' CG1' ' A' ' 17' ' ' ILE . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.763 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.767 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.763 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.767 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.063 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.909 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.82 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.675 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.114 HG12 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.777 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.114 HD13 HG12 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.664 0.268 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.493 ' HB3' ' HE2' ' A' ' 2' ' ' MET . 52.8 mtp -73.44 114.88 12.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.815 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.23 -170.24 55.05 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.32 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.74 -13.59 61.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.844 -1.178 . . . . 0.0 108.283 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.605 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.56 HD13 ' HG3' ' A' ' 9' ' ' LYS . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.605 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.584 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.584 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.739 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.801 HD13 HG22 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.739 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HB2' ' HB ' ' A' ' 32' ' ' VAL . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 27' ' ' ILE . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.487 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.747 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.076 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.747 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.801 HG22 HD13 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.95 HD12 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.866 HD22 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.714 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.546 ' HB3' HD12 ' A' ' 36' ' ' LEU . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.903 ' HB3' HD23 ' A' ' 60' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.579 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.613 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.076 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.773 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.719 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.749 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.832 HG11 HD12 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.753 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.471 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.95 ' HG ' HD12 ' A' ' 33' ' ' LEU . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.903 HD23 ' HB3' ' A' ' 43' ' ' ALA . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.6 mmt 59.15 55.08 4.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.348 0.594 . . . . 0.0 110.226 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.16 156.28 24.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.786 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? -79.27 1.6 24.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.457 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' H ' HG21 ' A' ' 7' ' ' VAL . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.534 ' HA ' ' HB1' ' A' ' 12' ' ' ALA . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.693 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.534 ' HB1' ' HA ' ' A' ' 9' ' ' LYS . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.785 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.803 HD12 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.785 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.803 HG13 HD12 ' A' ' 17' ' ' ILE . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.4 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 27' ' ' ILE . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.55 ' O ' HG12 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.033 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.711 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.765 ' CG1' HG11 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.919 HD21 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.977 HD22 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.745 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.539 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.518 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.977 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.033 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.418 ' CB ' HD11 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.489 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.63 HG13 ' HG ' ' A' ' 29' ' ' LEU . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.588 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.919 ' HB2' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.624 HD22 HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.003 0.43 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.6 mtt -120.33 -142.87 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.66 172.31 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.212 -1.471 . . . . 0.0 114.129 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -67.74 -19.81 65.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.883 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.697 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.751 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.751 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.697 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.666 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.739 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.58 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.64 HG12 ' HA ' ' A' ' 27' ' ' ILE . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.64 ' HA ' HG12 ' A' ' 21' ' ' VAL . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.619 ' O ' HG11 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.013 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.591 ' HD3' HG13 ' A' ' 54' ' ' VAL . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG11 ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.097 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.874 HD23 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.717 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.666 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.874 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.883 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.013 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.952 ' HB2' HD11 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.511 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.1 p80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.498 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.591 HG13 ' HD3' ' A' ' 30' ' ' PRO . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.658 ' HA ' HD13 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.483 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' CB ' HG23 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.097 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.524 ' O ' HD21 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.952 HD11 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.635 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.644 0.259 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 41.2 ttp -158.44 -105.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.93 -148.63 25.92 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.358 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -65.42 -22.71 66.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.637 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.541 HD21 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.637 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.792 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.764 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.646 HD12 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.764 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.775 HG12 HG12 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 21' ' ' VAL . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.63 ' O ' HG23 ' A' ' 27' ' ' ILE . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.039 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.692 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.775 HG12 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.619 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.836 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.619 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.523 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.836 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.039 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.815 ' HB3' HD11 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.635 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.72 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.658 ' O ' HD11 ' A' ' 58' ' ' LEU . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 1.084 ' HA ' HD23 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.403 ' HB3' ' CG2' ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.084 HD23 ' HA ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.552 ' O ' HD22 ' A' ' 60' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.857 ' HB2' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.466 0.174 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -80.97 86.36 6.11 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.91 31.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.902 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.5 tptt -66.66 -23.8 66.19 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.631 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.485 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.693 ' H ' HG11 ' A' ' 7' ' ' VAL . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.806 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.806 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.454 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.92 HD12 HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.454 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.92 HG12 HD12 ' A' ' 17' ' ' ILE . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.454 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.762 HD12 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.686 ' O ' HG11 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.035 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.875 ' HB3' HG22 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.737 ' CG1' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.735 HD11 ' HB3' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.403 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.884 HD23 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.884 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.631 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.035 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.538 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.562 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.931 ' SG ' HD12 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.711 ' HB3' HG21 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.844 HD21 ' HA ' ' A' ' 55' ' ' CYS . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.518 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.601 ' HB2' ' CD2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.503 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.701 0.286 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.35 -21.13 23.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -150.66 -165.79 13.04 Favored Glycine 0 CA--C 1.5 -0.861 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.594 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' HZ2' ' HG2' ' A' ' 40' ' ' GLU . 22.4 tptm -68.37 -6.5 24.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.808 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.626 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.609 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.609 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.626 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.648 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.614 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.815 ' HB ' HD23 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.733 HG11 ' CG1' ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.481 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.581 ' O ' HG21 ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.667 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.013 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.865 ' HG3' HG12 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.733 ' CG1' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.855 HD11 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.902 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.79 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.691 ' CB ' HD11 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' HZ2' ' A' ' 4' ' ' LYS . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.902 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.808 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.013 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.662 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.662 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.865 HG12 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 54' ' ' VAL . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.855 ' HG ' HD11 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.755 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.02 73.25 5.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.045 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.535 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 80.63 -161.97 44.87 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.126 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -83.03 16.24 2.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.72 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.595 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.834 HD11 ' H ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.595 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.676 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.676 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.747 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.717 HD11 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.747 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 27' ' ' ILE . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.485 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.733 ' O ' HG23 ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.617 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.041 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.666 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.617 HG11 ' O ' ' A' ' 28' ' ' ASP . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.794 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.819 HD23 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.794 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.636 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.819 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.678 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.72 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.041 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.797 ' HB3' HD23 ' A' ' 60' ' ' LEU . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.492 ' CE1' HG22 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.603 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.01 HG13 HD12 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.681 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' HB3' HG23 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.01 HD12 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.812 0.339 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.455 ' HB2' ' HE1' ' A' ' 2' ' ' MET . 16.7 ptm -80.31 61.98 4.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.861 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.84 170.53 47.14 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.22 -1.18 48.38 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.492 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.492 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.732 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.757 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.683 HD11 HG11 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.757 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.683 HG11 HD11 ' A' ' 17' ' ' ILE . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.6 ' O ' HG21 ' A' ' 27' ' ' ILE . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.572 ' O ' HG12 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.889 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.914 ' HB3' HG12 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.622 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.748 HD11 HD21 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.441 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.916 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.543 ' HB2' HD13 ' A' ' 36' ' ' LEU . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.432 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.889 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.684 ' CB ' HD22 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.515 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.472 ' HE1' ' CE1' ' A' ' 46' ' ' PHE . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.405 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.914 HG12 ' HB3' ' A' ' 30' ' ' PRO . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.691 ' HA ' HD22 ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.909 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.654 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.684 HD22 ' CB ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.513 0.197 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.3 mtm 58.2 -100.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.857 0.723 . . . . 0.0 111.078 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.438 ' HA3' ' HG ' ' A' ' 44' ' ' SER . . . 142.89 -176.77 22.3 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.191 -179.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.408 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm -62.01 -22.08 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.552 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.518 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.481 ' H ' HG12 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 12' ' ' ALA . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 11' ' ' VAL . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.552 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 ' CD1' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.561 ' N ' HG21 ' A' ' 17' ' ' ILE . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG12 ' HA ' ' A' ' 27' ' ' ILE . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.436 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.625 ' HA ' HG12 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.648 ' O ' HG12 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.077 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.751 HG22 ' CE1' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.934 HD23 ' HG2' ' A' ' 37' ' ' LYS . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.826 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.934 ' HG2' HD23 ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.408 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.742 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.637 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.503 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.077 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.626 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.637 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.626 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.626 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 HG12 ' HD3' ' A' ' 30' ' ' PRO . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.854 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.052 HD22 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.513 ' O ' HD22 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.052 ' HG ' HD22 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.615 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 13.7 ptp -108.2 -61.21 1.62 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.615 ' H ' ' HG3' ' A' ' 2' ' ' MET . . . -116.42 -159.01 11.58 Favored Glycine 0 CA--C 1.496 -1.147 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.909 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -71.96 -7.66 49.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.623 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.726 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.481 HG11 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.481 ' H ' HG11 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.726 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.734 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.988 HG12 HD21 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.734 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.795 ' HB1' HD11 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 1.001 HG11 HG12 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.663 ' N ' HG22 ' A' ' 21' ' ' VAL . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.523 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.535 HD11 HG12 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.71 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.86 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.838 ' HB3' HG12 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.63 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 1.001 HG12 HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.707 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.988 HD21 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.707 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.835 ' HA ' HD22 ' A' ' 36' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.623 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.86 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.88 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.536 ' ND1' HD13 ' A' ' 29' ' ' LEU . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.88 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.897 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.864 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' CB ' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.897 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.483 ' HB3' HD22 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.828 ' HB1' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 31.2 ttp -86.49 -93.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.42 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 76.15 -162.3 52.51 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.487 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm -77.58 -0.48 26.55 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.713 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.515 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.611 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.611 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.529 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.95 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.651 ' O ' ' HB3' ' A' ' 22' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.826 HG12 HD13 ' A' ' 17' ' ' ILE . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.651 ' HB3' ' O ' ' A' ' 18' ' ' ALA . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.557 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.67 ' HA ' HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.576 ' O ' HG12 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.097 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.494 ' HD2' ' C ' ' A' ' 28' ' ' ASP . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.773 HG22 HG13 ' A' ' 17' ' ' ILE . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.946 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.43 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.95 HD22 ' HB ' ' A' ' 17' ' ' ILE . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.619 ' CB ' HD13 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.43 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.934 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.713 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.097 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.844 ' HB3' HD13 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.828 ' HG3' ' HB1' ' A' ' 1' ' ' ALA . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.646 ' H ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.509 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.435 ' O ' HD11 ' A' ' 58' ' ' LEU . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.744 ' HA ' HD22 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.946 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.585 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.845 ' HG ' HD23 ' A' ' 58' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 121.086 0.47 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.7 mmt -101.87 159.39 15.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.78 -166.08 26.0 Favored Glycine 0 CA--C 1.493 -1.281 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.7 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -61.16 -25.58 67.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.489 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.743 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.611 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.597 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.611 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 16' ' ' ALA . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.771 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.543 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.688 HD12 HG12 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.771 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.688 HG12 HD12 ' A' ' 17' ' ' ILE . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.546 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.629 ' HA ' HG13 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.654 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.057 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.668 ' HB3' HG13 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 28' ' ' ASP . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.6 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.464 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.789 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.423 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.871 ' HB3' HD12 ' A' ' 60' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.743 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.057 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 1.066 ' HB3' HD21 ' A' ' 60' ' ' LEU . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.494 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.839 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.668 HG13 ' HB3' ' A' ' 30' ' ' PRO . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.712 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.541 ' CB ' HG23 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.712 ' HB2' ' HA ' ' A' ' 55' ' ' CYS . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.066 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.442 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 mmt -78.91 -81.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.23 0.538 . . . . 0.0 110.721 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.51 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -159.33 178.32 35.52 Favored Glycine 0 CA--C 1.501 -0.834 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.567 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.481 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp -74.35 0.84 13.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.524 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.512 ' C ' HG12 ' A' ' 7' ' ' VAL . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.512 HG12 ' C ' ' A' ' 6' ' ' SER . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.56 HD11 ' HG3' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.56 ' HG3' HD11 ' A' ' 8' ' ' LEU . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.639 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.621 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.744 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.899 HD13 HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.744 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.627 HG11 ' CD1' ' A' ' 17' ' ' ILE . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 18' ' ' ALA . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.536 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.6 HD13 HG13 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.718 ' O ' HG13 ' A' ' 32' ' ' VAL . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.02 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.663 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.899 HG23 HD13 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.582 HD23 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' HB1' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.621 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.831 ' HA ' HD23 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.639 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.02 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 1.114 ' HB3' HD22 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HD1' HD11 ' A' ' 29' ' ' LEU . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.822 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.701 ' CG1' HD12 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.622 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.758 HD21 HD12 ' A' ' 60' ' ' LEU . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.5 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 1.114 HD22 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.608 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.484 ' CE ' ' HA ' ' A' ' 2' ' ' MET . 8.2 mmt 59.84 39.59 20.37 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.851 0.72 . . . . 0.0 110.823 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.572 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 107.14 -175.48 20.55 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -80.56 12.14 3.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.688 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.525 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD21 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.609 ' HA ' ' HB2' ' A' ' 12' ' ' ALA . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.421 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.798 ' O ' ' HB1' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.886 HD12 ' HB1' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.798 ' HB1' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.886 ' HB1' HD12 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.835 HG13 HG13 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.615 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.57 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.699 HD11 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.515 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.941 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.722 ' HB3' HG13 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.835 HG13 HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.861 HD23 ' HB2' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.79 ' CD2' HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.425 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.714 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.699 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.688 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.941 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.699 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.77 ' O ' HD13 ' A' ' 58' ' ' LEU . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.831 ' HA ' HD22 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.411 ' HG2' ' HZ2' ' A' ' 56' ' ' LYS . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.916 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.916 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.506 ' HB3' ' H ' ' A' ' 2' ' ' MET . . . . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.506 ' H ' ' HB3' ' A' ' 1' ' ' ALA . 6.0 ttt -73.14 -76.77 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . 0.569 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 92.77 -177.2 38.55 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.706 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 9.67 7.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.678 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.617 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.48 ' O ' ' HG2' ' A' ' 10' ' ' LYS . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.405 ' H ' HG11 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.617 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.876 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.876 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.638 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.769 HD13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.638 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.831 HG12 ' HA ' ' A' ' 27' ' ' ILE . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.831 ' HA ' HG12 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.557 ' O ' HG11 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.049 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.651 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.48 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.669 HG23 HD13 ' A' ' 17' ' ' ILE . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.762 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 31' ' ' CYS . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.78 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.762 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.405 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.78 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.728 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.678 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.049 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.869 ' HB3' HD23 ' A' ' 60' ' ' LEU . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.728 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.529 ' N ' ' CD2' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.66 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 1.04 HG12 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.772 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG12 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.869 HD23 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.799 0.333 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm -77.47 -70.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.14 -158.64 53.43 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.899 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -65.09 -21.5 66.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.665 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG11 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.79 ' H ' HG11 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.665 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.943 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.841 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.772 ' HB2' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.572 ' N ' HG23 ' A' ' 21' ' ' VAL . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.436 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' ILE . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.603 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 1.079 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.862 ' CG2' HD13 ' A' ' 17' ' ' ILE . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 1.108 HD13 ' HG ' ' A' ' 58' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.943 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.422 ' HB3' ' O ' ' A' ' 36' ' ' LEU . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' CB ' HD23 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 1.079 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.697 ' HA ' ' CE1' ' A' ' 50' ' ' HIS . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.697 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.5 p80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.69 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.56 HG13 ' HG ' ' A' ' 29' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . 0.785 ' HA ' HD22 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 1.108 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 57.6 m170 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.683 ' HG ' ' CD2' ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.707 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.987 HG12 HG11 ' A' ' 32' ' ' VAL . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.103 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.737 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.987 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 58' ' ' LEU . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.947 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.103 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 1.12 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.557 ' HB3' HD13 ' A' ' 29' ' ' LEU . 2.1 m-70 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.545 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.514 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.12 HD12 ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 13.9 tppt? . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.615 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.028 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.077 HG12 HG11 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.784 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.756 HD13 HG11 ' A' ' 21' ' ' VAL . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.04 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.953 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.961 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.824 HD22 ' CG1' ' A' ' 17' ' ' ILE . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.796 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.04 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.679 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.953 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.762 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.961 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.025 HG12 HG11 ' A' ' 32' ' ' VAL . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.019 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.787 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.025 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.796 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.94 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.94 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.751 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.997 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.754 ' CA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.997 HD13 HG13 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.751 HD12 ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.659 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.976 HG12 HG11 ' A' ' 32' ' ' VAL . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 27' ' ' ILE . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.976 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.839 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.819 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.128 HG13 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.128 HD13 HG13 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.618 ' N ' HD23 ' A' ' 60' ' ' LEU . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 122.414 1.102 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.067 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.874 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.974 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.067 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.765 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.113 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.113 HD13 HG13 ' A' ' 54' ' ' VAL . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.778 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.663 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.856 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 21' ' ' VAL . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.053 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.751 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.053 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 30' ' ' PRO . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.746 ' HA ' HD21 ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.024 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.593 HD11 ' O ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.903 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.723 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.619 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.723 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.983 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 27' ' ' ILE . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.592 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.023 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.109 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.903 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.023 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.991 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 47' ' ' CYS . 3.8 p-80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.51 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.109 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.648 ' O ' HD23 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 15.0 tptm . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.649 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.05 HG12 HG11 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 21' ' ' VAL . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.064 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.05 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.061 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.791 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.064 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.901 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 44' ' ' SER . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.712 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' A' ' 30' ' ' PRO . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.061 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 26.5 tptt . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.506 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.818 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.818 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.763 HD13 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.047 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.836 ' HB3' HG21 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.89 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.047 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.699 ' HB3' HD12 ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.714 ' HD2' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.836 HG21 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.584 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 22.4 tptm . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.823 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.691 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.031 HG12 HG11 ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.998 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.039 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.998 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.707 ' CB ' HD12 ' A' ' 60' ' ' LEU . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.675 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.039 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.736 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.638 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 HG11 ' A' ' 32' ' ' VAL . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.105 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.686 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.979 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.913 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.736 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.105 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 46' ' ' PHE . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB3' HG22 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.913 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.805 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.948 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.93 ' HB3' HG11 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.02 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.865 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.865 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.948 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.742 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 58' ' ' LEU . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.02 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.691 ' C ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.658 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.644 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.065 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.007 HG21 HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.957 HD22 ' HB2' ' A' ' 58' ' ' LEU . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.85 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.739 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.809 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.065 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.749 ' CB ' HD12 ' A' ' 60' ' ' LEU . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.076 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.644 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.076 ' HG ' HD23 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.539 ' N ' ' HG ' ' A' ' 44' ' ' SER . 32.6 tttp . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.742 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.615 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.742 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.103 HG12 HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.926 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.058 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.978 HD23 HG12 ' A' ' 54' ' ' VAL 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.007 ' HB3' HG11 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.058 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.038 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.103 HD22 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 4' ' ' LYS . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.916 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.887 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.887 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 30' ' ' PRO . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.038 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.664 ' N ' HD23 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.529 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.644 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.027 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.569 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HB3' HG11 ' A' ' 54' ' ' VAL . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.027 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 1.033 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.924 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.924 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.658 ' CB ' HD12 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.656 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.607 ' HA ' HD21 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.033 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.603 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.867 HD11 HD11 ' A' ' 33' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.623 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.695 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.623 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.709 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.039 HG12 HG11 ' A' ' 32' ' ' VAL . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.598 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.112 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 1.032 ' HB3' HG11 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.039 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.848 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.802 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.112 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.852 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.852 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.074 HG12 HD23 ' A' ' 29' ' ' LEU . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.794 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.694 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.727 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' CB ' ' HA ' ' A' ' 5' ' ' CYS . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.964 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.066 HG12 HG11 ' A' ' 32' ' ' VAL . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.937 HD13 HG11 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.115 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HB3' HG21 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.066 HG11 HG12 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.925 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.115 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.997 ' HB3' HD21 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HE2' HD12 ' A' ' 27' ' ' ILE . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.831 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 6' ' ' SER . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.748 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 1.068 HG12 HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 1.019 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.076 HG12 HG11 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.833 HD13 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.708 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.037 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HB3' HG11 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.068 HD22 HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.914 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.709 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.037 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.87 ' HB3' HD12 ' A' ' 60' ' ' LEU . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.709 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' ND1' HD12 ' A' ' 29' ' ' LEU . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.718 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.41 ' O ' HD23 ' A' ' 60' ' ' LEU . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.876 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.63 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.884 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.884 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.99 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.0 HG12 HG11 ' A' ' 32' ' ' VAL . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.988 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.688 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.0 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.8 HD22 ' CG1' ' A' ' 17' ' ' ILE . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.731 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.988 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 1.099 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB3' HG22 ' A' ' 54' ' ' VAL . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.099 HD13 HG13 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.845 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' N ' HD23 ' A' ' 60' ' ' LEU . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.674 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.956 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 1.071 HG12 HG11 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 21' ' ' VAL . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 1.036 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 21' ' ' VAL . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.927 HD11 HD11 ' A' ' 60' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.956 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' HD22 ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 1.036 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.886 ' HB2' HD12 ' A' ' 60' ' ' LEU . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 47' ' ' CYS . 4.3 p-80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.691 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 58' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HA ' HD21 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.036 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' O ' HD23 ' A' ' 60' ' ' LEU . 3.0 m-70 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 1.036 ' HG ' HD23 ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.6 ttt -57.21 -56.82 16.82 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.633 0.583 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 87.38 -168.55 38.54 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.2 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt -84.11 36.98 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.707 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.987 HG12 HG11 ' A' ' 32' ' ' VAL . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.103 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.737 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.987 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 58' ' ' LEU . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.947 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.103 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 1.12 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 1' ' ' ALA . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.557 ' HB3' HD13 ' A' ' 29' ' ' LEU . 2.1 m-70 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.545 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.514 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.12 HD12 ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.495 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 7.5 ptp -119.16 122.32 41.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.934 0.397 . . . . 0.0 111.385 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 63.96 -152.2 48.89 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.514 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 13.9 tppt? -80.37 28.99 0.3 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' H ' ' C ' ' A' ' 3' ' ' GLY . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.615 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.028 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.077 HG12 HG11 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.784 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.756 HD13 HG11 ' A' ' 21' ' ' VAL . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.04 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.953 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.961 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.824 HD22 ' CG1' ' A' ' 17' ' ' ILE . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.796 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.04 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.679 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.953 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.762 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.961 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.564 0.221 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.1 ptm -106.02 100.98 10.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.264 0.554 . . . . 0.0 111.273 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 82.92 165.83 38.18 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.323 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm -81.68 31.46 0.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.025 HG12 HG11 ' A' ' 32' ' ' VAL . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.019 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.787 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.025 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.796 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.94 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.94 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.751 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.997 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.754 ' CA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.997 HD13 HG13 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.751 HD12 ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.273 0.083 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.3 mtt 68.39 -75.62 0.06 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.852 0.72 . . . . 0.0 112.64 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 97.84 -153.53 20.11 Favored Glycine 0 CA--C 1.492 -1.399 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -85.01 30.75 0.57 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.659 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.976 HG12 HG11 ' A' ' 32' ' ' VAL . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 27' ' ' ILE . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.976 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.839 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.819 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.128 HG13 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.128 HD13 HG13 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.618 ' N ' HD23 ' A' ' 60' ' ' LEU . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.664 0.268 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.8 mtp -73.44 114.88 12.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.23 -170.24 55.05 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.32 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.74 -13.59 61.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.844 -1.178 . . . . 0.0 108.283 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.067 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.874 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.974 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.067 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.765 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.113 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HA ' ' HD2' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.113 HD13 HG13 ' A' ' 54' ' ' VAL . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.778 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.6 mmt 59.15 55.08 4.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.348 0.594 . . . . 0.0 110.226 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.16 156.28 24.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.786 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? -79.27 1.6 24.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.663 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.856 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 21' ' ' VAL . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.053 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.751 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.053 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 30' ' ' PRO . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.746 ' HA ' HD21 ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.024 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.593 HD11 ' O ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.003 0.43 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.6 mtt -120.33 -142.87 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.66 172.31 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.212 -1.471 . . . . 0.0 114.129 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -67.74 -19.81 65.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.903 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.723 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.619 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.723 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.983 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 27' ' ' ILE . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.592 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.023 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.109 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.903 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.023 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.991 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.431 ' CD2' ' HA ' ' A' ' 47' ' ' CYS . 3.8 p-80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.51 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.109 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.648 ' O ' HD23 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.646 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.644 0.259 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 41.2 ttp -158.44 -105.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.93 -148.63 25.92 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.358 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 15.0 tptm -65.42 -22.71 66.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.649 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.612 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.05 HG12 HG11 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 21' ' ' VAL . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.064 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.05 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.061 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.791 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.064 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.901 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.712 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' A' ' 30' ' ' PRO . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' O ' ' HD2' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.061 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.466 0.174 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -80.97 86.36 6.11 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.91 31.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.902 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 26.5 tptt -66.66 -23.8 66.19 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.506 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HD23 ' A' ' 8' ' ' LEU . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.818 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.818 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.763 HD13 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.047 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.836 ' HB3' HG21 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.89 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.047 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.699 ' HB3' HD12 ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.714 ' HD2' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.836 HG21 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.584 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.701 0.286 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.35 -21.13 23.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -150.66 -165.79 13.04 Favored Glycine 0 CA--C 1.5 -0.861 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.594 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 22.4 tptm -68.37 -6.5 24.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.823 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.691 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.031 HG12 HG11 ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.998 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.039 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.998 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.707 ' CB ' HD12 ' A' ' 60' ' ' LEU . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.675 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.039 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.02 73.25 5.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.045 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 80.63 -161.97 44.87 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.126 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -83.03 16.24 2.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.736 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.638 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 HG11 ' A' ' 32' ' ' VAL . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.105 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.686 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.979 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.913 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.736 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.105 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 46' ' ' PHE . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB3' HG22 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.913 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.812 0.339 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 16.7 ptm -80.31 61.98 4.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.861 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.84 170.53 47.14 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.22 -1.18 48.38 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.805 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.948 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.93 ' HB3' HG11 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.02 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.865 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.865 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.948 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.742 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 58' ' ' LEU . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.02 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.691 ' C ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.513 0.197 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.3 mtm 58.2 -100.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.857 0.723 . . . . 0.0 111.078 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.89 -176.77 22.3 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.191 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm -62.01 -22.08 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.658 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.644 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.065 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.007 HG21 HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.957 HD22 ' HB2' ' A' ' 58' ' ' LEU . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.85 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.739 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.809 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.065 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.749 ' CB ' HD12 ' A' ' 60' ' ' LEU . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.076 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.644 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.076 ' HG ' HD23 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 13.7 ptp -108.2 -61.21 1.62 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.613 ' H ' ' HG3' ' A' ' 2' ' ' MET . . . -116.42 -159.01 11.58 Favored Glycine 0 CA--C 1.496 -1.147 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.909 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -71.96 -7.66 49.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.742 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.615 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.742 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.103 HG12 HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.926 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.058 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.978 HD23 HG12 ' A' ' 54' ' ' VAL 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.007 ' HB3' HG11 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.058 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.038 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.103 HD22 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.916 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.887 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.887 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 30' ' ' PRO . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.038 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.664 ' N ' HD23 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' CB ' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 31.2 ttp -86.49 -93.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 76.15 -162.3 52.51 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.487 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm -77.58 -0.48 26.55 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.529 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.644 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.027 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.569 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HB3' HG11 ' A' ' 54' ' ' VAL . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.027 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 1.033 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.924 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.924 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.658 ' CB ' HD12 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 1' ' ' ALA . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.656 ' CD2' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.607 ' HA ' HD21 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.033 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.603 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.867 HD11 HD11 ' A' ' 33' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 121.086 0.47 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.7 mmt -101.87 159.39 15.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.78 -166.08 26.0 Favored Glycine 0 CA--C 1.493 -1.281 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.7 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HA ' ' HE2' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -61.16 -25.58 67.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.489 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.623 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.695 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.623 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.709 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.039 HG12 HG11 ' A' ' 32' ' ' VAL . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.598 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.112 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 1.032 ' HB3' HG11 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.039 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.848 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.802 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.112 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.852 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.477 ' CE1' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.852 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.074 HG12 HD23 ' A' ' 29' ' ' LEU . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.794 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.694 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 mmt -78.91 -81.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.23 0.538 . . . . 0.0 110.721 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -159.33 178.32 35.52 Favored Glycine 0 CA--C 1.501 -0.834 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.567 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp -74.35 0.84 13.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.727 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' CB ' ' HA ' ' A' ' 5' ' ' CYS . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.964 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.066 HG12 HG11 ' A' ' 32' ' ' VAL . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.937 HD13 HG11 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.115 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HB3' HG21 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.066 HG11 HG12 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.925 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.115 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.997 ' HB3' HD21 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HE2' HD12 ' A' ' 27' ' ' ILE . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.831 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.494 ' CE ' ' HA ' ' A' ' 2' ' ' MET . 8.2 mmt 59.84 39.59 20.37 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.851 0.72 . . . . 0.0 110.823 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 107.14 -175.48 20.55 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -80.56 12.14 3.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.683 ' H ' HD23 ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 6' ' ' SER . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.748 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 1.068 HG12 HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 1.019 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.076 HG12 HG11 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.833 HD13 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.708 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.037 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HB3' HG11 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.068 HD22 HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.914 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.709 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.037 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.87 ' HB3' HD12 ' A' ' 60' ' ' LEU . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.709 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' ND1' HD12 ' A' ' 29' ' ' LEU . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.718 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' O ' HD23 ' A' ' 60' ' ' LEU . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.876 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.0 ttt -73.14 -76.77 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 92.77 -177.2 38.55 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.706 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 9.67 7.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.63 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.884 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.884 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.99 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.0 HG12 HG11 ' A' ' 32' ' ' VAL . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.988 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.688 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.0 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.8 HD22 ' CG1' ' A' ' 17' ' ' ILE . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.731 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.988 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' N ' ' HG3' ' A' ' 48' ' ' GLU . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.495 ' CE1' ' O ' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 1.099 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB3' HG22 ' A' ' 54' ' ' VAL . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.099 HD13 HG13 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.845 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' N ' HD23 ' A' ' 60' ' ' LEU . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.799 0.333 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm -77.47 -70.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.14 -158.64 53.43 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.899 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -65.09 -21.5 66.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.674 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.956 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 1.071 HG12 HG11 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 21' ' ' VAL . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 1.036 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 21' ' ' VAL . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.927 HD11 HD11 ' A' ' 60' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.956 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' HD22 ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 1.036 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.886 ' HB2' HD12 ' A' ' 60' ' ' LEU . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.553 ' CD2' ' HA ' ' A' ' 47' ' ' CYS . 4.3 p-80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.691 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 58' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HA ' HD21 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.036 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' O ' HD23 ' A' ' 60' ' ' LEU . 3.0 m-70 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 1.036 ' HG ' HD23 ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt . . . . . 0 N--CA 1.444 -0.747 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.707 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.987 HG12 HG11 ' A' ' 32' ' ' VAL . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.103 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.737 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.987 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 58' ' ' LEU . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.947 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.103 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 1.12 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.579 ' HE1' HD12 ' A' ' 27' ' ' ILE . 6.9 m170 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.545 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.514 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.12 HD12 ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 13.9 tppt? . . . . . 0 N--CA 1.449 -0.504 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.518 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.615 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.028 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.077 HG12 HG11 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.784 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.756 HD13 HG11 ' A' ' 21' ' ' VAL . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.04 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.953 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.077 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.961 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.824 HD22 ' CG1' ' A' ' 17' ' ' ILE . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.796 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.04 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.679 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.953 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.762 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.961 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm . . . . . 0 CA--C 1.521 -0.151 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.025 HG12 HG11 ' A' ' 32' ' ' VAL . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.019 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.787 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.025 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.796 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.94 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.94 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.751 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.603 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.439 ' HE1' HD12 ' A' ' 27' ' ' ILE . 1.5 m170 -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.997 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.754 ' CA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.997 HD13 HG13 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.751 HD12 ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? . . . . . 0 N--CA 1.439 -1.014 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.659 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.976 HG12 HG11 ' A' ' 32' ' ' VAL . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 27' ' ' ILE . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.976 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.839 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.819 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.128 HG13 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.128 HD13 HG13 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.618 ' N ' HD23 ' A' ' 60' ' ' LEU . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt . . . . . 0 N--CA 1.442 -0.862 0 CA-C-O 122.414 1.102 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.067 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.874 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.974 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.067 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.765 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.113 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.113 HD13 HG13 ' A' ' 54' ' ' VAL . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.778 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? . . . . . 0 CA--C 1.521 -0.172 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.663 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.856 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 21' ' ' VAL . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.053 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.751 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.053 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 30' ' ' PRO . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.746 ' HA ' HD21 ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.024 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.593 HD11 ' O ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? . . . . . 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.903 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.723 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.619 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.723 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.983 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 27' ' ' ILE . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.592 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.023 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.109 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.903 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.023 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.991 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.1 p80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.51 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.109 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.648 ' O ' HD23 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 15.0 tptm . . . . . 0 N--CA 1.45 -0.427 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.649 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.584 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.05 HG12 HG11 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 21' ' ' VAL . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.064 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.05 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.061 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.791 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.064 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.901 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 44' ' ' SER . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.712 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' A' ' 30' ' ' PRO . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.061 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 26.5 tptt . . . . . 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.506 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.818 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.818 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.763 HD13 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.047 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.836 ' HB3' HG21 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.89 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.047 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.699 ' HB3' HD12 ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.836 HG21 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.584 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 22.4 tptm . . . . . 0 N--CA 1.456 -0.126 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.823 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.691 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.031 HG12 HG11 ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.998 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.039 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.998 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.707 ' CB ' HD12 ' A' ' 60' ' ' LEU . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.675 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.039 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.45 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp . . . . . 0 N--CA 1.442 -0.832 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.736 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.638 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.638 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 HG11 ' A' ' 32' ' ' VAL . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.105 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.686 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.979 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.913 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.736 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.105 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 46' ' ' PHE . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.466 ' HE1' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB3' HG22 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.913 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? . . . . . 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.805 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.948 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.93 ' HB3' HG11 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.02 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.865 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.865 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.948 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.742 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 58' ' ' LEU . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.02 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.691 HD23 ' C ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.658 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.528 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.644 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.065 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.007 HG21 HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.957 HD22 ' HB2' ' A' ' 58' ' ' LEU . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.85 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.739 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.809 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.065 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.749 ' CB ' HD12 ' A' ' 60' ' ' LEU . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.076 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.644 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.076 ' HG ' HD23 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.539 ' N ' ' HG ' ' A' ' 44' ' ' SER . 32.6 tttp . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.742 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.615 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.615 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.742 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.103 HG12 HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.926 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.058 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.978 HD23 HG12 ' A' ' 54' ' ' VAL 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.007 ' HB3' HG11 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.058 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.038 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.103 HD22 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.539 ' HG ' ' N ' ' A' ' 4' ' ' LYS . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.916 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.887 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.887 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 30' ' ' PRO . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.038 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.012 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.664 ' N ' HD23 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm . . . . . 0 N--CA 1.445 -0.682 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.529 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.644 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.027 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.569 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HB3' HG11 ' A' ' 54' ' ' VAL . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.027 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 1.033 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.924 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.924 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.733 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.658 ' CB ' HD12 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.701 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.607 ' HA ' HD21 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.033 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.603 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.867 HD11 HD11 ' A' ' 33' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.623 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.592 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.623 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.709 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.039 HG12 HG11 ' A' ' 32' ' ' VAL . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.598 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.112 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 1.032 ' HB3' HG11 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.039 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.848 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.802 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.112 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.852 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.852 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.074 HG12 HD23 ' A' ' 29' ' ' LEU . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.794 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.694 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp . . . . . 0 N--CA 1.455 -0.208 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.727 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.727 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.503 ' CB ' ' HA ' ' A' ' 5' ' ' CYS . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.964 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.066 HG12 HG11 ' A' ' 32' ' ' VAL . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.937 HD13 HG11 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.115 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HB3' HG21 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.066 HG11 HG12 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.925 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.115 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.997 ' HB3' HD21 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HE2' HD12 ' A' ' 27' ' ' ILE . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.831 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 6' ' ' SER . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.748 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 1.068 HG12 HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 1.019 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.076 HG12 HG11 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.833 HD13 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.708 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.037 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HB3' HG11 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.068 HD22 HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.914 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.709 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.037 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.87 ' HB3' HD12 ' A' ' 60' ' ' LEU . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.709 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.508 ' ND1' HD12 ' A' ' 29' ' ' LEU . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.746 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.718 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.41 ' O ' HD23 ' A' ' 60' ' ' LEU . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.876 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.63 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.884 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.884 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.99 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.0 HG12 HG11 ' A' ' 32' ' ' VAL . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.988 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.688 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.0 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.8 HD22 ' CG1' ' A' ' 17' ' ' ILE . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.731 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.988 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 1.099 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB3' HG22 ' A' ' 54' ' ' VAL . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.099 HD13 HG13 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.845 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.467 ' N ' HD23 ' A' ' 60' ' ' LEU . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? . . . . . 0 N--CA 1.445 -0.701 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.674 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.616 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.956 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 1.071 HG12 HG11 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 21' ' ' VAL . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 1.036 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 21' ' ' VAL . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.927 HD11 HD11 ' A' ' 60' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.956 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' HD22 ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 1.036 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.886 ' HB2' HD12 ' A' ' 60' ' ' LEU . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . 0.713 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.5 p80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.691 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 58' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HA ' HD21 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.036 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.573 ' O ' HD23 ' A' ' 60' ' ' LEU . 57.6 m170 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 1.036 ' HG ' HD23 ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.426 ' N ' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.484 1.234 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 15.6 ttt -57.21 -56.82 16.82 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 123.633 0.583 . . . . 0.0 110.536 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.517 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 87.38 -168.55 38.54 Favored Glycine 0 CA--C 1.501 -0.836 0 C-N-CA 119.566 -1.302 . . . . 0.0 113.2 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.559 ' HB2' ' HA3' ' A' ' 41' ' ' GLY . 27.2 ttpt -84.11 36.98 0.59 Allowed 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 106.476 -1.675 . . . . 0.0 106.476 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -137.67 91.92 2.64 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.52 -175.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.515 ' O ' ' HB2' ' A' ' 10' ' ' LYS . 48.3 m -68.88 -176.53 0.86 Allowed 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.6 m -51.8 -46.2 39.42 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -71.78 -45.36 61.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.786 0.326 . . . . 0.0 110.461 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -79.72 7.27 8.84 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 120.347 -0.541 . . . . 0.0 111.2 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 6' ' ' SER . 38.8 tttp -87.32 -14.64 40.26 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 106.052 -1.833 . . . . 0.0 106.052 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -92.4 -23.95 5.49 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 CA-C-N 113.365 -1.743 . . . . 0.0 107.436 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.35 -14.91 26.3 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.628 -1.623 . . . . 0.0 113.057 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.707 ' O ' HG22 ' A' ' 17' ' ' ILE . 3.4 p -68.38 -30.37 69.28 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.597 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.648 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.81 -25.49 68.27 Favored 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 123.56 0.537 . . . . 0.0 109.868 178.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.41 -35.58 17.01 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.442 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.97 -51.45 64.29 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 115.474 -0.784 . . . . 0.0 110.657 178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.792 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -77.76 -23.48 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.462 179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.75 -41.46 23.21 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 179.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.96 -22.05 70.12 Favored Glycine 0 CA--C 1.518 0.253 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.395 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -84.05 -40.62 18.13 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 122.943 -0.151 . . . . 0.0 111.112 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.987 HG12 HG11 ' A' ' 32' ' ' VAL . 28.9 m -69.04 -38.0 77.76 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.781 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.61 -23.28 64.59 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.68 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.05 -23.26 52.07 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.466 178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.9 t -110.6 -51.45 2.87 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.06 58.26 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.973 -0.632 . . . . 0.0 111.66 -179.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.408 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 105.34 179.13 24.04 Favored Glycine 0 N--CA 1.453 -0.204 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 21' ' ' VAL . 16.9 mm -65.99 82.06 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 122.135 0.969 . . . . 0.0 111.355 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.536 ' O ' HG13 ' A' ' 32' ' ' VAL . 9.6 t70 -105.58 79.35 1.44 Allowed 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 102.255 -3.239 . . . . 0.0 102.255 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.103 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.272 0.2 OUTLIER -42.69 -47.14 12.91 Favored Pre-proline 0 N--CA 1.442 -0.837 0 N-CA-C 115.813 1.782 . . . . 0.0 115.813 -173.342 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.737 ' HD3' HG11 ' A' ' 54' ' ' VAL . 36.5 Cg_endo -68.32 -19.15 44.22 Favored 'Trans proline' 0 C--N 1.349 0.585 0 CA-C-N 121.476 1.563 . . . . 0.0 111.967 178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.515 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 1.4 t -86.87 -53.18 5.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.973 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.987 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -65.38 -34.65 71.9 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.666 0 CA-C-N 116.808 -0.178 . . . . 0.0 111.188 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.83 HD22 ' HG ' ' A' ' 58' ' ' LEU . 2.4 tp -58.37 -30.92 67.16 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.68 -36.99 86.06 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-O 121.121 0.486 . . . . 0.0 111.082 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -93.7 -41.52 9.66 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.179 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.947 HD21 ' HA ' ' A' ' 43' ' ' ALA . 21.8 tp -66.99 -19.53 65.73 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.855 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.633 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 4.8 tmtp? -60.87 -17.12 48.53 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.844 -177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.59 -28.52 69.41 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.16 54.01 3.02 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 114.312 -1.313 . . . . 0.0 108.146 176.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -48.85 101.11 0.03 OUTLIER 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.597 0.713 . . . . 0.0 111.534 -178.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' ' HB2' ' A' ' 4' ' ' LYS . . . 123.04 -21.38 7.42 Favored Glycine 0 N--CA 1.434 -1.492 0 C-N-CA 120.02 -1.086 . . . . 0.0 113.943 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -106.54 1.2 25.19 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 119.73 1.765 . . . . 0.0 108.266 178.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.947 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -74.41 -30.64 62.01 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 174.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 48.4 t -63.1 -24.42 67.89 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 112.93 -1.941 . . . . 0.0 109.336 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.687 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 3.4 t -77.53 -39.65 45.34 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.103 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 15.1 t80 -62.85 -57.67 10.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.766 -1.561 . . . . 0.0 110.433 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 1.12 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -74.9 -2.11 25.46 Favored 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -179.179 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.426 ' HG3' ' N ' ' A' ' 1' ' ' ALA . 44.1 tt0 -58.22 -56.7 18.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 118.31 0.505 . . . . 0.0 111.25 -178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -80.05 -17.95 51.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.176 0.512 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.579 ' HE1' HD12 ' A' ' 27' ' ' ILE . 6.9 m170 -99.14 34.16 2.21 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.02 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.545 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 37.2 t -77.73 81.66 4.16 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 116.046 -0.524 . . . . 0.0 112.29 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HB2' ' H ' ' A' ' 53' ' ' GLY . 9.5 p80 -155.4 -153.57 0.45 Allowed 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.82 179.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' H ' ' HB2' ' A' ' 52' ' ' HIS . . . -19.12 -77.59 0.01 OUTLIER Glycine 0 C--N 1.348 1.241 0 O-C-N 124.796 1.31 . . . . 0.0 115.047 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -99.35 109.18 23.88 Favored 'Isoleucine or valine' 1 N--CA 1.378 -4.039 0 N-CA-C 104.472 -2.418 . . . . 0.0 104.472 177.603 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.774 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 12.4 t 165.69 -33.89 0.0 OUTLIER 'General case' 0 C--N 1.251 -3.699 0 N-CA-C 101.534 -3.506 . . . . 0.0 101.534 -175.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -83.62 -32.93 25.44 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-N 110.992 -2.822 . . . . 0.0 104.446 172.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.47 ' HB3' HG22 ' A' ' 54' ' ' VAL . 0.9 OUTLIER -82.75 -35.15 26.87 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 113.866 -1.515 . . . . 0.0 107.899 176.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.5 mp -62.29 -33.16 74.12 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 114.185 -1.37 . . . . 0.0 108.233 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.514 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.7 t60 81.06 48.86 0.02 OUTLIER 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 124.959 1.304 . . . . 0.0 112.352 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.12 HD12 ' HB2' ' A' ' 47' ' ' CYS . 17.6 mt -120.0 -62.36 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.818 178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 11.9 p . . . . . 0 C--O 1.246 0.902 0 CA-C-O 118.399 -0.81 . . . . 0.0 110.468 -179.573 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.185 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.495 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 7.5 ptp -119.16 122.32 41.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.934 0.397 . . . . 0.0 111.385 -179.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 63.96 -152.2 48.89 Favored Glycine 0 CA--C 1.501 -0.784 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.514 179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 13.9 tppt? -80.37 28.99 0.3 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 122.348 1.07 . . . . 0.0 108.25 178.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' H ' ' C ' ' A' ' 3' ' ' GLY . 54.6 m -127.99 89.34 2.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 114.413 -1.267 . . . . 0.0 112.094 -175.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.615 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 m -74.37 -160.2 0.1 Allowed 'General case' 0 C--O 1.225 -0.226 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.648 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.7 p -62.2 -58.54 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.662 0.744 . . . . 0.0 110.063 179.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.648 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.3 tp -64.14 -39.09 93.29 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.504 -1.226 . . . . 0.0 110.722 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB2' ' N ' ' A' ' 6' ' ' SER . 13.6 mmmt -70.26 -18.66 63.14 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.703 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.1 tttp -78.14 -16.19 58.17 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 121.509 0.671 . . . . 0.0 109.575 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.74 -26.66 6.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 178.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -82.54 -30.09 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.221 -1.354 . . . . 0.0 112.7 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.466 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 p -67.89 -30.0 69.24 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 118.375 0.534 . . . . 0.0 110.708 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.96 -24.36 67.5 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.756 -179.199 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -98.87 -35.72 10.01 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.8 178.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.63 -55.42 20.37 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.644 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.028 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -72.64 -34.27 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 C-N-CA 120.34 -0.544 . . . . 0.0 110.842 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.39 -38.2 58.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.778 0.323 . . . . 0.0 110.356 178.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.25 -25.93 75.03 Favored Glycine 0 C--N 1.332 0.335 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.536 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.82 -39.28 26.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 O-C-N 122.972 -0.134 . . . . 0.0 111.27 179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.077 HG12 HG11 ' A' ' 32' ' ' VAL . 26.3 m -67.08 -39.96 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.749 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.5 -26.85 61.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.302 -1.317 . . . . 0.0 110.493 178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.52 -28.72 69.84 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -104.46 -53.25 2.74 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.782 179.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 162.95 -42.64 0.34 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.835 -0.506 . . . . 0.0 111.835 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.784 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -157.69 -154.14 6.99 Favored Glycine 0 N--CA 1.45 -0.381 0 N-CA-C 109.957 -1.257 . . . . 0.0 109.957 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.756 HD13 HG11 ' A' ' 21' ' ' VAL . 20.7 mm -69.12 71.85 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 122.559 1.171 . . . . 0.0 111.344 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 32' ' ' VAL . 2.5 m-20 -94.19 78.92 4.0 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 102.644 -3.095 . . . . 0.0 102.644 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.04 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.266 1.2 tt -47.67 -41.09 34.61 Favored Pre-proline 0 N--CA 1.435 -1.177 0 CA-C-N 114.669 -1.15 . . . . 0.0 113.237 -174.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.953 ' HB3' HG11 ' A' ' 54' ' ' VAL . 44.0 Cg_endo -70.32 -20.75 31.81 Favored 'Trans proline' 0 C--N 1.363 1.301 0 C-N-CA 121.535 1.49 . . . . 0.0 112.675 176.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 20.7 t -91.97 -49.26 6.32 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.077 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -60.32 -27.48 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -176.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.961 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.98 11.19 0.58 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -179.631 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.88 -46.16 7.31 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -90.92 -39.03 12.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.875 178.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.824 HD22 ' CG1' ' A' ' 17' ' ' ILE . 18.9 tp -68.54 -22.61 64.49 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.172 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.681 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.6 tptm -57.88 -27.0 62.88 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 119.404 -0.918 . . . . 0.0 111.196 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.3 29.23 0.36 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.642 177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -98.73 19.16 15.28 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.572 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 75.2 tt0 60.36 14.94 5.05 Favored 'General case' 0 N--CA 1.466 0.368 0 O-C-N 124.162 0.914 . . . . 0.0 109.737 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 96.38 45.38 2.78 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.648 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.43 19.36 20.72 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.796 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -73.0 -22.24 60.71 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 113.144 -1.844 . . . . 0.0 108.072 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.61 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 47.1 t -62.03 -18.21 59.81 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 114.276 -1.329 . . . . 0.0 109.277 177.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.518 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -83.03 -41.04 19.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.991 178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.04 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.0 t80 -67.5 -67.1 0.48 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.432 -179.518 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 8.5 t -82.25 34.73 0.42 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -178.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' HB3' ' O ' ' A' ' 44' ' ' SER . 1.9 pp20? -90.29 -31.28 17.01 Favored 'General case' 0 C--N 1.33 -0.256 0 O-C-N 121.706 -0.621 . . . . 0.0 109.487 178.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -87.45 -41.06 13.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.777 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.679 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.0 p80 -111.63 52.53 0.75 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.906 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.73 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.3 t -75.77 82.37 2.73 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.032 0.444 . . . . 0.0 110.277 178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -169.58 -171.89 1.32 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.876 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.94 -111.27 3.64 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.762 178.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.953 HG11 ' HB3' ' A' ' 30' ' ' PRO . 0.9 OUTLIER -94.3 5.14 7.82 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.203 0 O-C-N 122.963 -0.139 . . . . 0.0 111.129 -178.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.686 ' HA ' HD22 ' A' ' 58' ' ' LEU . 4.4 t -61.41 -19.67 62.21 Favored 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.9 ttmm -73.51 -44.55 57.5 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 114.646 -1.161 . . . . 0.0 108.179 177.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.762 ' HB3' HG22 ' A' ' 54' ' ' VAL . 23.5 t70 -69.47 -34.79 74.9 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.843 177.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.961 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.3 mp -51.29 -63.82 1.01 Allowed 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 113.856 -1.52 . . . . 0.0 108.397 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 4.6 m80 95.63 57.31 0.0 OUTLIER 'General case' 0 CA--C 1.486 -1.515 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.849 HD12 HD11 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -141.85 -49.86 0.39 Allowed 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 111.582 -2.554 . . . . 0.0 108.223 -176.061 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.9 t . . . . . 0 C--O 1.247 0.944 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.25 179.646 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 120.564 0.221 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 17.1 ptm -106.02 100.98 10.5 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.264 0.554 . . . . 0.0 111.273 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.514 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 82.92 165.83 38.18 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.323 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.623 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.8 tptm -81.68 31.46 0.36 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 122.174 0.987 . . . . 0.0 108.392 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.949 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 42.5 m -130.3 109.68 10.95 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.407 -1.269 . . . . 0.0 110.509 -176.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.572 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 56.4 p -75.59 -163.19 0.24 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.859 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.622 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.0 p -54.92 -59.16 2.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.415 0.626 . . . . 0.0 111.07 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.7 OUTLIER -71.09 -29.08 64.84 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.633 -179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.572 ' HB2' ' N ' ' A' ' 6' ' ' SER . 84.6 mttt -78.97 -12.47 60.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.859 -0.337 . . . . 0.0 110.744 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 6' ' ' SER . 11.0 tptp -80.92 -26.9 36.39 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.473 HG12 ' O ' ' A' ' 8' ' ' LEU . 0.4 OUTLIER -86.01 -25.99 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.65 178.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.3 -26.06 22.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.346 -1.297 . . . . 0.0 113.473 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.699 ' O ' HG22 ' A' ' 17' ' ' ILE . 1.2 p -66.81 -35.66 80.58 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 119.062 0.846 . . . . 0.0 110.666 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -66.15 -32.07 73.29 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 123.382 0.426 . . . . 0.0 110.204 179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.05 -25.96 36.71 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.626 0.727 . . . . 0.0 109.987 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -79.84 -53.07 7.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.965 -1.016 . . . . 0.0 111.904 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.699 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -74.8 -28.23 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -52.99 -35.89 59.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.86 0.362 . . . . 0.0 110.743 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -73.48 -25.56 72.28 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.434 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -78.99 -34.66 43.91 Favored 'General case' 0 CA--C 1.514 -0.414 0 N-CA-C 111.473 0.175 . . . . 0.0 111.473 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.025 HG12 HG11 ' A' ' 32' ' ' VAL . 25.7 m -71.69 -38.6 67.11 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.919 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.15 -24.36 58.61 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.418 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.19 -25.46 63.44 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.264 178.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.535 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -112.64 -54.59 2.61 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 173.43 -47.39 0.16 Allowed Glycine 0 CA--C 1.521 0.454 0 C-N-CA 120.456 -0.878 . . . . 0.0 113.792 -179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 171.7 104.3 0.17 Allowed Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.214 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 27' ' ' ILE . 20.5 mm 42.89 51.15 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 CA-C-O 122.783 1.278 . . . . 0.0 111.732 -178.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.535 ' OD2' ' HB3' ' A' ' 24' ' ' CYS . 37.1 m-20 -88.27 76.77 8.34 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 102.656 -3.09 . . . . 0.0 102.656 175.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.019 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.28 0.2 OUTLIER -38.94 -47.53 3.69 Favored Pre-proline 0 N--CA 1.444 -0.762 0 N-CA-C 116.314 1.968 . . . . 0.0 116.314 -172.724 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.787 ' HG3' HG11 ' A' ' 54' ' ' VAL . 13.0 Cg_exo -67.2 -25.87 42.76 Favored 'Trans proline' 0 C--N 1.349 0.565 0 CA-C-N 121.602 1.608 . . . . 0.0 111.807 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 3.3 t -84.66 -51.05 7.12 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.074 -0.966 . . . . 0.0 112.681 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.025 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.58 -27.82 43.73 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.796 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 3.4 tp -66.85 -1.85 4.45 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.481 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.33 -52.79 4.86 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.46 -40.5 35.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.667 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.94 HD21 ' HA ' ' A' ' 43' ' ' ALA . 27.5 tp -69.48 -19.96 63.74 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.137 0.494 . . . . 0.0 111.458 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 9.5 ttpp -67.65 -15.47 63.66 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.885 -1.126 . . . . 0.0 110.415 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.29 -7.27 58.17 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.709 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.5 174.36 1.33 Allowed 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.055 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -78.26 44.71 0.51 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.571 0.7 . . . . 0.0 109.429 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.623 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 63.83 47.93 81.49 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.334 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.76 17.08 16.26 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.94 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.18 -24.97 67.52 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 114.688 -1.142 . . . . 0.0 107.955 177.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.565 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 25.6 t -65.57 -25.44 67.42 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.743 -1.117 . . . . 0.0 108.925 177.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.949 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 19.3 t -71.22 -32.38 68.73 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.019 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 22.2 t80 -67.96 -66.49 0.56 Allowed 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.022 -1.899 . . . . 0.0 112.037 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.751 ' SG ' HD12 ' A' ' 60' ' ' LEU . 0.5 OUTLIER -90.98 10.33 27.02 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.997 1.48 . . . . 0.0 114.997 -177.689 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.603 ' OE2' ' HA ' ' A' ' 45' ' ' CYS . 15.9 pt-20 -62.15 -36.5 82.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 119.917 1.235 . . . . 0.0 109.88 178.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -83.82 -19.18 35.41 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.493 178.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.439 ' HE1' HD12 ' A' ' 27' ' ' ILE . 1.5 m170 -105.88 37.57 2.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.901 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.615 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 38.5 t -71.7 80.59 0.85 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.253 0.549 . . . . 0.0 111.432 -177.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 23.2 p80 -151.83 -156.35 0.7 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.882 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -19.5 -74.52 0.01 OUTLIER Glycine 0 C--N 1.343 0.942 0 O-C-N 124.849 1.343 . . . . 0.0 115.327 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.997 HG13 HD13 ' A' ' 58' ' ' LEU . 0.4 OUTLIER -104.1 94.53 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.855 0 CA-C-O 126.89 3.233 . . . . 0.0 107.83 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.754 ' CA ' ' HB2' ' A' ' 58' ' ' LEU . 50.2 t 177.49 -28.18 0.0 OUTLIER 'General case' 0 C--N 1.252 -3.662 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 -177.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.445 ' HA ' ' HE3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -90.72 -31.88 16.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 110.171 -3.195 . . . . 0.0 104.492 172.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.629 ' HB3' HG23 ' A' ' 54' ' ' VAL . 0.7 OUTLIER -88.47 -28.94 20.52 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.616 176.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.997 HD13 HG13 ' A' ' 54' ' ' VAL . 1.2 mp -68.79 -15.3 63.47 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.255 178.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 67.2 40.15 2.89 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.349 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.751 HD12 ' SG ' ' A' ' 47' ' ' CYS . 11.7 mt -111.86 -56.47 2.38 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.472 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.491 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 11.7 p . . . . . 0 C--O 1.242 0.704 0 CA-C-O 118.554 -0.736 . . . . 0.0 109.802 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.29 0 CA-C-O 120.273 0.083 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 54.3 mtt 68.39 -75.62 0.06 Allowed 'General case' 0 N--CA 1.47 0.528 0 O-C-N 123.852 0.72 . . . . 0.0 112.64 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 97.84 -153.53 20.11 Favored Glycine 0 CA--C 1.492 -1.399 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.709 -178.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -85.01 30.75 0.57 Allowed 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 105.974 -1.862 . . . . 0.0 105.974 177.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.699 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 9.0 m -129.46 114.65 16.39 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.687 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.9 m -65.74 174.32 2.4 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 120.503 0.192 . . . . 0.0 111.344 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -53.96 -62.25 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-O 120.921 0.391 . . . . 0.0 111.577 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.659 ' H ' HG13 ' A' ' 7' ' ' VAL . 1.1 pt? -68.32 -25.45 65.12 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.532 179.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -80.35 -2.68 46.47 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.884 0.373 . . . . 0.0 110.621 178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 11.5 ttmt -79.86 -7.9 58.98 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 177.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -96.31 -24.55 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 CA-C-N 114.12 -1.4 . . . . 0.0 108.889 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -90.72 -13.9 33.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.67 -1.15 . . . . 0.0 112.523 -179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.501 ' O ' HG22 ' A' ' 17' ' ' ILE . 8.5 p -68.07 -24.33 65.05 Favored 'General case' 0 CA--C 1.507 -0.699 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.17 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -63.26 -43.7 97.24 Favored 'General case' 0 C--O 1.212 -0.917 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.22 -25.89 68.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.783 178.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -80.35 -55.37 4.94 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.969 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -79.41 -29.99 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.299 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.432 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -49.17 -36.2 18.91 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 118.38 0.536 . . . . 0.0 111.351 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -63.91 -28.92 73.44 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.5 -0.857 . . . . 0.0 111.51 178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.492 ' HB1' ' O ' ' A' ' 32' ' ' VAL . . . -81.07 -36.97 29.78 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.976 HG12 HG11 ' A' ' 32' ' ' VAL . 33.2 m -70.71 -36.25 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.826 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.226 178.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.21 -31.0 63.08 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 113.764 -1.562 . . . . 0.0 109.045 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -62.99 -37.52 87.46 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.45 178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 -71.53 0.68 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.501 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.8 -31.16 0.07 OUTLIER Glycine 0 C--N 1.338 0.693 0 C-N-CA 119.698 -1.239 . . . . 0.0 114.556 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 169.67 99.81 0.13 Allowed Glycine 0 C--N 1.33 0.236 0 C-N-CA 120.274 -0.965 . . . . 0.0 112.873 -179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.642 HG22 ' O ' ' A' ' 27' ' ' ILE . 23.6 mm 42.92 54.52 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-O 122.911 1.338 . . . . 0.0 113.078 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 1.9 m-20 -91.75 76.59 5.64 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 102.669 -3.086 . . . . 0.0 102.669 174.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.996 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.2 pt? -40.13 -42.09 2.7 Favored Pre-proline 0 CA--C 1.547 0.851 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -173.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.712 ' HG3' HG11 ' A' ' 54' ' ' VAL . 6.0 Cg_exo -71.54 -25.84 20.63 Favored 'Trans proline' 0 C--N 1.359 1.128 0 CA-C-N 121.791 1.675 . . . . 0.0 111.695 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 5.7 t -83.31 -48.6 10.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.274 -0.876 . . . . 0.0 111.987 -178.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.976 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.93 -33.13 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 120.877 -0.329 . . . . 0.0 110.272 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.873 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -70.42 -0.62 8.65 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.838 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -89.85 -21.49 22.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.415 0.626 . . . . 0.0 109.417 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.25 -42.0 3.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.716 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.759 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.0 tp -67.83 -18.14 64.74 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.244 178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 48.3 tttm -58.36 -13.9 6.33 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.647 -176.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -59.48 -32.3 70.13 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.87 62.36 6.34 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 113.225 -1.807 . . . . 0.0 108.102 175.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -67.03 76.93 0.13 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.394 0.616 . . . . 0.0 109.671 -178.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 149.57 -16.11 1.1 Allowed Glycine 0 N--CA 1.434 -1.493 0 CA-C-N 115.425 -0.807 . . . . 0.0 113.337 -178.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.32 2.86 24.81 Favored 'General case' 0 CA--C 1.495 -1.158 0 CA-C-N 119.537 1.669 . . . . 0.0 107.885 178.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.952 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -66.58 -30.77 71.14 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 113.206 -1.815 . . . . 0.0 107.116 175.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 26.3 t -57.37 -30.18 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.145 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.699 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 5.3 t -72.22 -44.11 63.42 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.996 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.3 t80 -55.43 -65.49 0.58 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 113.861 -1.518 . . . . 0.0 110.553 178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.839 ' HB3' HD21 ' A' ' 60' ' ' LEU . 4.7 t -81.23 9.97 6.16 Favored 'General case' 0 C--O 1.218 -0.604 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 -177.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.49 -52.05 56.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.545 1.066 . . . . 0.0 112.247 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -69.14 -50.19 50.1 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.951 0.405 . . . . 0.0 110.999 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.819 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.8 p80 -97.15 45.04 1.04 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.688 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.0 OUTLIER -76.61 65.01 2.34 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.253 0.549 . . . . 0.0 110.402 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -152.27 177.62 10.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.886 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 64.9 -105.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.942 -0.647 . . . . 0.0 113.528 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.128 HG13 HD13 ' A' ' 58' ' ' LEU . 1.7 p -90.11 -3.24 10.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 O-C-N 122.957 -0.143 . . . . 0.0 110.951 -179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.779 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 3.0 t -63.98 -17.12 62.99 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.5 ttmp? -80.29 -35.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.432 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.7 t70 -76.46 -32.84 58.63 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 114.595 -1.184 . . . . 0.0 107.847 177.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.128 HD13 HG13 ' A' ' 54' ' ' VAL . 1.3 mp -61.22 -41.3 96.62 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.598 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 55.03 72.18 0.49 Allowed 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.008 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.952 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -139.31 -13.06 1.18 Allowed 'General case' 0 N--CA 1.438 -1.045 0 CA-C-N 114.985 -1.007 . . . . 0.0 112.136 -176.528 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.618 ' N ' HD23 ' A' ' 60' ' ' LEU . 30.0 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.472 179.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.2 0 CA-C-O 120.664 0.268 . . . . 0.0 110.829 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 52.8 mtp -73.44 114.88 12.16 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.815 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 77.23 -170.24 55.05 Favored Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 119.891 -1.147 . . . . 0.0 113.32 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 12.1 tttt -72.74 -13.59 61.36 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 113.844 -1.178 . . . . 0.0 108.283 178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.629 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.6 m -79.78 95.56 6.04 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.139 -179.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.616 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 77.1 p -74.12 -173.18 1.56 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.637 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -50.29 -59.06 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 121.422 0.63 . . . . 0.0 111.573 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.637 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.4 pp -68.83 -27.7 66.08 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.195 -0.911 . . . . 0.0 111.612 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB2' ' N ' ' A' ' 6' ' ' SER . 67.6 mttm -78.4 -20.56 50.88 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.64 0.257 . . . . 0.0 110.988 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.575 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 18.2 mttt -75.45 -2.6 29.5 Favored 'General case' 0 CA--C 1.522 -0.127 0 CA-C-O 121.157 0.503 . . . . 0.0 110.509 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -95.34 -27.56 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.44 -19.11 25.54 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.996 -178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.575 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.1 p -66.84 -32.58 73.96 Favored 'General case' 0 CA--C 1.506 -0.724 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.624 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.33 -26.76 68.62 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.35 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.2 -34.03 13.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.397 0.618 . . . . 0.0 109.514 178.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -65.07 -56.5 12.65 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.094 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.801 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -73.39 -32.37 36.83 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 120.311 -0.555 . . . . 0.0 111.505 -179.223 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.552 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.67 -35.11 41.18 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.599 0.237 . . . . 0.0 110.95 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -68.26 -26.4 74.19 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.722 -0.751 . . . . 0.0 111.47 178.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.29 -41.3 20.32 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 111.354 0.131 . . . . 0.0 111.354 179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.955 HG12 HG11 ' A' ' 32' ' ' VAL . 27.7 m -66.82 -35.74 75.5 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.768 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.78 -27.73 66.8 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.854 -1.067 . . . . 0.0 109.88 178.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -71.05 -25.42 62.64 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.051 178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.6 m -101.5 -45.51 5.27 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.258 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.49 16.54 2.52 Favored Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 146.58 -179.28 23.67 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -62.53 94.35 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.426 0 CA-C-O 122.053 0.93 . . . . 0.0 112.38 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.765 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 41.1 t0 -119.71 85.0 2.3 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 103.413 -2.81 . . . . 0.0 103.413 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.067 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.8 OUTLIER -45.72 -44.19 30.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 N-CA-C 115.553 1.686 . . . . 0.0 115.553 -174.235 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.629 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 69.3 Cg_endo -76.28 -5.23 16.0 Favored 'Trans proline' 0 C--N 1.356 0.952 0 CA-C-N 121.635 1.62 . . . . 0.0 111.811 178.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.765 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 35.8 t -98.97 -55.37 2.73 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.816 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.955 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.76 -29.39 47.25 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.501 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.615 -177.671 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.874 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -69.69 0.55 5.36 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -179.393 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.37 -35.95 16.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.61 -37.52 9.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.984 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.974 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.3 tp -70.89 -17.75 62.7 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.831 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 32.5 ttmt -61.98 -13.91 30.07 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.032 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.65 68.18 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.27 74.2 10.35 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -48.64 88.26 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 O-C-N 124.347 1.029 . . . . 0.0 113.273 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.02 15.01 53.79 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.693 -0.765 . . . . 0.0 114.456 178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -109.21 6.44 24.71 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 119.645 1.722 . . . . 0.0 107.604 177.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.974 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.2 -19.57 59.74 Favored 'General case' 0 N--CA 1.426 -1.675 0 CA-C-N 112.226 -2.261 . . . . 0.0 106.887 175.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HA ' ' HB3' ' A' ' 60' ' ' LEU . 8.0 t -63.88 -21.8 66.62 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.221 177.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.629 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 13.1 t -85.69 -10.92 54.96 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-O 121.972 0.891 . . . . 0.0 109.662 178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.067 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.9 t80 -93.57 -66.19 0.94 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 114.316 -1.311 . . . . 0.0 111.302 -178.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.778 ' SG ' ' HB2' ' A' ' 60' ' ' LEU . 0.5 OUTLIER -80.41 17.62 1.05 Allowed 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 44' ' ' SER . 13.9 pt-20 -68.72 -34.15 75.15 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-O 121.101 0.477 . . . . 0.0 109.879 178.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.89 -52.03 9.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.39 178.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.718 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 3.9 p80 -101.26 64.1 1.01 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.627 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.765 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 24.1 t -80.51 63.82 5.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.094 179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.404 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 37.2 p-80 -154.61 -173.75 4.7 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.676 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.33 -109.16 1.58 Allowed Glycine 0 CA--C 1.509 -0.288 0 CA-C-N 116.012 -0.54 . . . . 0.0 113.758 178.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.113 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -97.72 -0.98 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 O-C-N 122.996 -0.12 . . . . 0.0 111.023 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.765 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 0.5 OUTLIER -64.77 -13.25 54.6 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.244 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 34.4 tptt -84.68 -35.89 22.27 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.7 t70 -71.41 -37.39 71.5 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 176.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.113 HD13 HG13 ' A' ' 54' ' ' VAL . 2.3 mp -57.18 -33.74 67.77 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 112.702 -2.045 . . . . 0.0 108.074 177.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.2 t60 59.01 64.59 1.37 Allowed 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.795 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.778 ' HB2' ' SG ' ' A' ' 47' ' ' CYS . 29.7 mt -117.42 -46.87 2.67 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.601 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 55' ' ' CYS . 0.8 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.805 -0.616 . . . . 0.0 111.289 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 25.6 mmt 59.15 55.08 4.53 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.348 0.594 . . . . 0.0 110.226 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 103.16 156.28 24.91 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.406 -0.902 . . . . 0.0 111.786 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 2.2 ttmp? -79.27 1.6 24.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.113 0.959 . . . . 0.0 108.93 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.476 ' SG ' ' HB3' ' A' ' 9' ' ' LYS . 7.4 m -119.87 90.51 3.34 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.759 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.537 ' O ' ' HG3' ' A' ' 10' ' ' LYS . 23.4 m -74.32 -171.59 1.23 Allowed 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.142 -179.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' HD3' ' A' ' 10' ' ' LYS . 11.0 m -35.67 -48.0 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 -178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -74.67 -50.37 17.9 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.837 0.351 . . . . 0.0 110.363 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.476 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 81.1 mttt -71.55 -3.63 22.43 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.663 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 60.0 mtpt -75.26 -14.88 60.55 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 176.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -93.53 -24.35 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 CA-C-N 113.972 -1.467 . . . . 0.0 107.713 178.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.05 -8.05 43.97 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 114.295 -1.32 . . . . 0.0 113.126 -179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.663 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.2 m -63.81 -29.03 70.27 Favored 'General case' 0 CA--C 1.504 -0.825 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.557 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -68.01 -40.64 82.95 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.869 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.32 -24.7 66.58 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.177 0.513 . . . . 0.0 110.699 178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -93.52 -50.03 5.62 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.472 -0.786 . . . . 0.0 112.853 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.856 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -93.11 -38.95 10.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 -177.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -53.56 -30.48 42.23 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 119.025 0.83 . . . . 0.0 110.672 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.18 -27.39 72.94 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.117 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.06 -39.71 48.91 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 122.246 0.219 . . . . 0.0 110.801 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 15.4 m -68.65 -38.67 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.761 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.28 -24.88 63.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.481 -1.236 . . . . 0.0 109.642 178.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -80.74 -31.72 35.88 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.6 178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.42 ' HB2' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m -95.73 -58.8 2.01 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 -179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 174.35 -39.36 0.13 Allowed Glycine 0 CA--C 1.522 0.488 0 C-N-CA 119.717 -1.23 . . . . 0.0 114.351 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 158.6 96.66 0.12 Allowed Glycine 0 C--O 1.235 0.169 0 C-N-CA 120.179 -1.01 . . . . 0.0 112.43 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 21' ' ' VAL . 30.4 mm 44.01 47.03 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.38 0 CA-C-O 123.329 1.538 . . . . 0.0 111.945 -178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -87.91 75.68 8.79 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 103.029 -2.952 . . . . 0.0 103.029 174.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.053 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.7 OUTLIER -39.63 -45.07 3.82 Favored Pre-proline 0 N--CA 1.444 -0.757 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 -173.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.751 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 55.6 Cg_endo -72.52 -9.93 24.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 CA-C-N 121.355 1.519 . . . . 0.0 112.348 178.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 11.7 t -101.69 -50.2 3.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.138 -0.483 . . . . 0.0 112.027 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -59.61 -37.76 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.024 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -72.03 -10.0 59.17 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 111.779 0.288 . . . . 0.0 111.779 -178.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.4 -27.15 60.51 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.4 178.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.13 -37.01 7.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.18 178.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.92 HD21 ' HA ' ' A' ' 43' ' ' ALA . 17.4 tp -71.6 -16.39 62.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.282 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.754 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 79.4 tttt -68.69 -26.98 65.57 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 118.628 -1.229 . . . . 0.0 109.144 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -81.47 1.33 33.76 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 114.782 -1.099 . . . . 0.0 110.142 178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.52 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.68 178.57 2.04 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -79.84 47.51 0.87 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.093 0.473 . . . . 0.0 110.398 178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 61.62 45.42 96.35 Favored Glycine 0 C--O 1.221 -0.691 0 CA-C-N 115.171 -0.922 . . . . 0.0 114.052 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 14.3 t -110.13 8.75 23.95 Favored 'General case' 0 CA--C 1.509 -0.598 0 CA-C-N 118.681 1.24 . . . . 0.0 109.408 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.92 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.7 -26.28 68.59 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.119 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.602 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 21.1 t -66.12 -21.71 66.36 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.411 178.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.7 t -81.21 -40.25 24.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 122.157 0.979 . . . . 0.0 108.404 177.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.053 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 10.1 t80 -58.3 -67.43 0.35 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 113.424 -1.716 . . . . 0.0 113.142 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.35 9.88 8.14 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -177.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB2' ' O ' ' A' ' 44' ' ' SER . 19.1 tp10 -74.59 -46.83 36.1 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 118.642 0.655 . . . . 0.0 110.274 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 54.2 t0 -69.08 -38.64 79.12 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.574 0.702 . . . . 0.0 110.206 179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.489 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -98.14 33.33 2.19 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.057 -179.539 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.2 m -59.25 89.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.9 p-80 179.78 176.5 0.69 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.134 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.93 -109.8 2.05 Favored Glycine 0 N--CA 1.45 -0.38 0 N-CA-C 114.697 0.639 . . . . 0.0 114.697 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 30' ' ' PRO . 4.4 p -90.23 -6.59 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 -177.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.746 ' HA ' HD21 ' A' ' 58' ' ' LEU . 79.9 m -62.28 -14.36 38.03 Favored 'General case' 0 N--CA 1.475 0.795 0 O-C-N 121.528 -0.732 . . . . 0.0 109.221 177.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -92.14 -21.52 20.37 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 177.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 9.1 t0 -83.33 -51.07 7.74 Favored 'General case' 0 C--N 1.334 -0.087 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.387 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.024 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -74.31 9.57 1.63 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -179.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.3 m170 60.52 74.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.177 0.991 . . . . 0.0 112.051 178.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.593 HD11 ' O ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -121.73 -65.39 1.13 Allowed 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.805 -1.088 . . . . 0.0 111.176 -178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 6.2 p . . . . . 0 C--O 1.247 0.936 0 CA-C-O 117.772 -1.109 . . . . 0.0 109.647 179.37 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.052 0 CA-C-O 121.003 0.43 . . . . 0.0 110.626 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 61.6 mtt -120.33 -142.87 0.35 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 126.66 172.31 13.28 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 119.212 -1.471 . . . . 0.0 114.129 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.5 tppp? -67.74 -19.81 65.17 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 122.835 1.303 . . . . 0.0 108.462 177.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.903 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 10.7 m -80.78 79.98 7.33 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.612 -2.085 . . . . 0.0 112.751 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.723 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 16.7 t -75.42 -161.65 0.16 Allowed 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.619 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.4 p -56.07 -59.36 2.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.438 0.637 . . . . 0.0 111.105 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.619 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -76.31 -23.07 54.3 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.717 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.723 ' HB2' ' H ' ' A' ' 6' ' ' SER . 8.5 mmmm -85.6 -6.55 59.15 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 120.634 0.255 . . . . 0.0 110.775 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.97 -21.37 47.21 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 178.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.32 -22.76 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.228 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.54 -25.33 23.7 Favored 'General case' 0 N--CA 1.455 -0.19 0 CA-C-N 113.772 -1.558 . . . . 0.0 112.987 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.679 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 10.3 p -65.39 -28.61 69.38 Favored 'General case' 0 CA--C 1.508 -0.662 0 C-N-CA 119.491 -0.884 . . . . 0.0 109.746 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -70.55 -42.91 70.53 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.75 -24.86 67.69 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.094 0.473 . . . . 0.0 110.709 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -88.03 -51.98 5.51 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.443 -0.799 . . . . 0.0 112.856 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.705 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -87.7 -34.27 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 -177.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.93 -29.17 59.7 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 118.936 0.789 . . . . 0.0 109.878 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -75.21 -25.12 69.39 Favored Glycine 0 N--CA 1.45 -0.395 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.04 -39.55 29.61 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 122.451 0.3 . . . . 0.0 110.889 178.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.983 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.4 -38.73 82.41 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.748 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.89 -26.97 64.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.005 178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.27 -27.63 61.67 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.789 -0.642 . . . . 0.0 110.391 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 12.6 t -104.96 -54.57 2.47 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 144.63 30.06 0.09 OUTLIER Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.538 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 130.16 -178.56 17.46 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.803 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.539 HG22 ' O ' ' A' ' 27' ' ' ILE . 13.1 mm -66.98 84.22 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 122.557 1.17 . . . . 0.0 111.445 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.592 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.2 t0 -113.99 87.22 2.57 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 103.265 -2.865 . . . . 0.0 103.265 176.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.023 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -44.92 -42.13 14.62 Favored Pre-proline 0 N--CA 1.446 -0.666 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -174.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.624 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.8 Cg_endo -77.29 -9.05 17.62 Favored 'Trans proline' 0 C--N 1.354 0.839 0 CA-C-N 121.471 1.561 . . . . 0.0 112.046 178.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 1.1 t -99.58 -49.32 4.44 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.29 -178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.983 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -69.59 -36.96 73.26 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 C-N-CA 120.96 -0.296 . . . . 0.0 110.868 -178.459 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.109 HD13 ' HG ' ' A' ' 58' ' ' LEU . 1.7 tt -69.31 -16.33 63.53 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 111.9 0.334 . . . . 0.0 111.9 -178.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.09 -31.53 72.78 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 177.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.5 -37.16 8.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.097 -0.956 . . . . 0.0 110.224 178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.826 HD21 ' HA ' ' A' ' 43' ' ' ALA . 28.9 tp -68.41 -20.03 64.64 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.65 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.724 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 18.4 tttp -63.47 -24.38 67.8 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.198 -1.001 . . . . 0.0 110.619 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.61 9.48 21.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.88 179.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.566 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.81 179.42 2.22 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.54 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 80.5 tt0 -70.05 3.45 2.73 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 121.697 0.761 . . . . 0.0 109.948 178.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 98.69 42.7 2.84 Favored Glycine 0 N--CA 1.441 -1.001 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.413 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.679 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -112.14 20.07 17.18 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.496 179.533 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.826 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.71 -23.3 63.4 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 33.3 t -65.04 -21.31 66.81 Favored 'General case' 0 N--CA 1.446 -0.669 0 CA-C-N 114.216 -1.356 . . . . 0.0 109.745 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.903 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 34.4 t -85.74 -31.82 22.2 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 122.133 0.968 . . . . 0.0 108.836 177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.023 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 27.7 t80 -64.03 -64.55 0.86 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 114.299 -1.318 . . . . 0.0 110.112 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.991 ' HB2' HD12 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -75.28 8.34 2.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -178.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.645 ' HG2' ' O ' ' A' ' 45' ' ' CYS . 16.1 pt-20 -72.48 -24.92 61.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.803 1.183 . . . . 0.0 110.352 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -88.3 -45.7 9.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.133 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.522 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.1 p80 -111.72 65.25 0.62 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.578 0.704 . . . . 0.0 111.205 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.51 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 17.9 t -83.36 63.49 7.3 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.381 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 31.4 p-80 -151.22 175.55 12.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.05 -115.93 8.05 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.695 -0.684 . . . . 0.0 114.725 177.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.707 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.2 p -79.82 -3.5 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.764 0 CA-C-N 115.687 -0.257 . . . . 0.0 110.951 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.581 ' HA ' HD21 ' A' ' 58' ' ' LEU . 22.2 t -64.87 -15.42 61.89 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.014 0.911 . . . . 0.0 108.604 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 56' ' ' LYS . 5.2 tmmm? -87.66 -15.38 37.36 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.194 -1.366 . . . . 0.0 108.08 178.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.474 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.0 t70 -94.68 -46.62 6.85 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.188 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.109 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.19 -10.84 59.66 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -178.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.648 ' O ' HD23 ' A' ' 60' ' ' LEU . 86.4 m-70 66.86 75.9 0.31 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 176.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.991 HD12 ' HB2' ' A' ' 47' ' ' CYS . 25.7 mt -126.61 -58.49 1.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.032 0.444 . . . . 0.0 110.484 177.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.5 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.189 -179.427 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.646 ' HA ' ' OE1' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.157 0 CA-C-O 120.644 0.259 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 41.2 ttp -158.44 -105.53 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.41 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 82.93 -148.63 25.92 Favored Glycine 0 CA--C 1.499 -0.926 0 C-N-CA 119.95 -1.119 . . . . 0.0 110.358 -177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 15.0 tptm -65.42 -22.71 66.8 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 177.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.799 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.2 m -75.94 111.49 11.37 Favored 'General case' 0 N--CA 1.441 -0.887 0 CA-C-N 113.184 -1.825 . . . . 0.0 110.533 178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.649 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 13.7 t -70.81 -171.46 0.53 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.6 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.584 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -51.4 -57.31 3.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.341 0.591 . . . . 0.0 111.829 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.612 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -71.79 -29.46 64.48 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.835 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.649 ' HB2' ' N ' ' A' ' 6' ' ' SER . 31.8 mmtp -74.14 -14.13 60.92 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.464 179.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -68.67 -21.69 64.43 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 122.04 0.924 . . . . 0.0 108.655 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.71 -23.26 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.227 0 CA-C-N 114.261 -1.336 . . . . 0.0 109.467 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.6 -25.83 18.99 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.799 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 2.0 p -62.59 -29.6 70.72 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-N 118.918 0.781 . . . . 0.0 111.064 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -65.5 -50.33 65.66 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.44 -28.59 69.34 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.107 0.479 . . . . 0.0 110.678 178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -73.05 -54.79 7.65 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.667 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -80.46 -32.13 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -178.338 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.0 -36.37 28.26 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.269 0.486 . . . . 0.0 111.563 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.73 -24.47 71.27 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.814 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -82.49 -40.17 21.45 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 122.19 0.196 . . . . 0.0 111.45 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.05 HG12 HG11 ' A' ' 32' ' ' VAL . 18.9 m -67.91 -40.19 83.02 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.73 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.64 63.0 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.863 178.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.5 -25.24 59.23 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.041 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 11.0 t -107.16 -51.02 2.98 Favored 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -178.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.93 -41.51 0.25 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.318 -0.944 . . . . 0.0 113.902 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 159.75 105.33 0.21 Allowed Glycine 0 CA--C 1.519 0.304 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.28 -179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.612 HD13 HG11 ' A' ' 21' ' ' VAL . 27.8 mm 37.03 63.43 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 CA-C-O 123.17 1.462 . . . . 0.0 113.269 -179.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.587 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.4 m-20 -104.58 81.9 1.84 Allowed 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 102.809 -3.034 . . . . 0.0 102.809 174.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.064 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -40.71 -45.98 6.04 Favored Pre-proline 0 N--CA 1.445 -0.694 0 N-CA-C 116.731 2.122 . . . . 0.0 116.731 -172.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.73 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 60.6 Cg_endo -74.96 -15.88 20.61 Favored 'Trans proline' 0 C--N 1.349 0.575 0 CA-C-N 121.809 1.682 . . . . 0.0 111.877 178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.4 ' CB ' ' HB3' ' A' ' 28' ' ' ASP . 4.1 t -90.53 -49.1 6.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.734 -179.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.05 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -67.93 -35.88 73.64 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.568 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.714 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.061 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -68.77 -9.39 50.61 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -76.78 -29.02 55.89 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 178.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.2 -39.83 5.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.361 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.791 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.5 tp -65.42 -22.74 66.8 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 115.307 -0.861 . . . . 0.0 111.195 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.62 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.8 tmtp? -57.9 -21.05 41.45 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.03 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.94 -3.93 32.0 Favored 'General case' 0 C--O 1.231 0.098 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.862 179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -69.65 175.67 4.04 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -76.33 28.56 0.12 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.124 0.488 . . . . 0.0 110.059 178.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.495 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 78.83 39.65 20.01 Favored Glycine 0 N--CA 1.438 -1.215 0 N-CA-C 110.951 -0.859 . . . . 0.0 110.951 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -102.59 15.65 28.66 Favored 'General case' 0 CA--C 1.506 -0.723 0 CA-C-O 121.699 0.761 . . . . 0.0 109.076 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.791 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -66.65 -20.49 66.0 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.034 -1.439 . . . . 0.0 108.27 176.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 1.8 p -65.85 -34.47 78.23 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 113.964 -1.471 . . . . 0.0 108.984 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.424 ' HB3' ' HB2' ' A' ' 13' ' ' CYS . 7.0 t -68.75 -40.16 79.95 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.064 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.9 t80 -60.62 -66.4 0.53 Allowed 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 113.655 -1.611 . . . . 0.0 110.891 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.901 ' HB3' HD12 ' A' ' 60' ' ' LEU . 4.6 t -86.76 42.83 1.04 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.646 ' OE1' ' HA ' ' A' ' 1' ' ' ALA . 82.8 tt0 -92.72 -42.87 9.36 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -71.67 -47.54 53.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.414 178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.712 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.6 p80 -98.59 47.99 0.98 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.895 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 1.9 t -73.43 80.47 1.41 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.628 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -174.75 178.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.004 -178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 58.55 -107.15 1.03 Allowed Glycine 0 N--CA 1.451 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 114.057 178.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.712 HG11 ' HD3' ' A' ' 30' ' ' PRO . 6.3 p -89.08 -4.07 10.16 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.699 ' HA ' HD21 ' A' ' 58' ' ' LEU . 2.5 t -61.45 -18.38 58.67 Favored 'General case' 0 N--CA 1.483 1.225 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.5 ' HD2' ' O ' ' A' ' 56' ' ' LYS . 1.1 tmmt? -91.85 -20.62 21.27 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.1 t70 -83.5 -49.69 9.01 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.393 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.061 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -72.68 -3.74 26.87 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 120.529 -0.468 . . . . 0.0 111.632 -179.879 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 14.0 m80 74.92 73.15 0.1 Allowed 'General case' 0 CA--C 1.503 -0.854 0 C-N-CA 124.242 1.017 . . . . 0.0 109.384 178.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.901 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -137.07 -73.31 0.43 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 115.142 -0.936 . . . . 0.0 112.873 -176.492 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' O ' ' HB3' ' A' ' 55' ' ' CYS . 52.7 t . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.1 -177.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.466 0.174 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 28.1 ttt -80.97 86.36 6.11 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -156.66 162.91 31.89 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.902 -178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.417 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 26.5 tptt -66.66 -23.8 66.19 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 176.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 5.4 m -104.02 84.86 2.3 Favored 'General case' 0 N--CA 1.432 -1.346 0 CA-C-N 112.094 -2.321 . . . . 0.0 109.99 -179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.506 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 34.3 m -63.99 -175.67 0.16 Allowed 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 120.366 0.127 . . . . 0.0 110.935 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.617 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p -53.19 -60.53 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 0.0 111.653 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 8' ' ' LEU . 2.5 pt? -70.2 -23.23 62.91 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.506 ' HB2' ' N ' ' A' ' 6' ' ' SER . 59.6 mttm -85.04 -13.05 51.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.698 0.285 . . . . 0.0 111.404 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.818 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 9.7 ptmt -81.99 -5.18 58.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.988 0.899 . . . . 0.0 109.394 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.17 -25.82 6.74 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 CA-C-N 114.652 -1.158 . . . . 0.0 108.333 177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -93.74 -22.23 18.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.522 -1.217 . . . . 0.0 113.521 -178.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.818 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.8 OUTLIER -68.14 -30.89 70.13 Favored 'General case' 0 CA--C 1.502 -0.894 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.044 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.543 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.0 -32.19 73.64 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.63 -33.01 28.01 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.804 178.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.82 -53.32 48.73 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.283 179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.765 HD11 HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -74.52 -23.5 18.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.974 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.267 179.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.26 -37.13 45.5 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 120.808 0.337 . . . . 0.0 111.15 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.39 -22.55 77.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.273 -0.965 . . . . 0.0 112.207 179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.402 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -85.34 -40.21 16.78 Favored 'General case' 0 CA--C 1.512 -0.49 0 C-N-CA 122.196 0.198 . . . . 0.0 111.173 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 29.0 m -66.14 -37.08 78.97 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.847 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.55 -28.35 59.89 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.332 -1.304 . . . . 0.0 110.157 177.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.03 -28.16 68.0 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.066 178.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -105.38 -30.56 9.52 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.718 179.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.17 19.34 5.17 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.769 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.575 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 147.94 -174.81 27.54 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.763 HD13 HG11 ' A' ' 21' ' ' VAL . 15.4 mm -65.45 80.98 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 122.255 1.026 . . . . 0.0 111.581 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.558 ' O ' HG13 ' A' ' 32' ' ' VAL . 32.6 m-20 -107.02 75.34 1.03 Allowed 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 175.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.047 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 5.9 tt -44.45 -43.29 15.95 Favored Pre-proline 0 C--N 1.318 -0.762 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.836 ' HB3' HG21 ' A' ' 54' ' ' VAL . 43.1 Cg_endo -70.13 -10.88 29.28 Favored 'Trans proline' 0 C--N 1.354 0.854 0 CA-C-N 121.026 1.402 . . . . 0.0 112.483 178.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 53.4 t -101.12 -52.97 3.14 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -178.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.003 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -58.49 -28.62 36.66 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.05 -176.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.741 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.33 10.47 0.78 Allowed 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 120.191 -0.604 . . . . 0.0 112.076 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.78 -39.95 8.38 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 177.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -92.11 -40.19 11.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.731 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.2 tp -67.64 -23.9 65.39 Favored 'General case' 0 CA--C 1.505 -0.753 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.49 178.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.638 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.9 tptt -56.19 -16.15 4.85 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.382 -177.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.79 -28.67 64.22 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.4 118.39 14.15 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.32 -26.27 2.98 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -177.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 178.78 43.56 0.07 OUTLIER Glycine 0 N--CA 1.441 -1.033 0 C-N-CA 119.357 -1.401 . . . . 0.0 114.374 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.668 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -106.7 8.66 31.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-N 118.842 1.321 . . . . 0.0 107.905 177.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.89 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -71.96 -21.45 61.59 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 113.845 -1.525 . . . . 0.0 107.118 176.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 32.9 p -60.68 -36.44 78.76 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-N 112.679 -2.055 . . . . 0.0 108.789 177.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.649 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 51.5 t -71.79 -47.07 56.0 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 113.561 -1.654 . . . . 0.0 109.521 178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.047 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 2.2 t80 -54.38 -59.24 4.95 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 114.607 -1.178 . . . . 0.0 108.629 178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.699 ' HB3' HD12 ' A' ' 60' ' ' LEU . 34.8 t -90.35 55.95 3.21 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 120.111 -0.635 . . . . 0.0 111.066 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -100.2 -50.25 4.02 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -78.47 -32.57 48.39 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.164 178.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.538 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -100.3 41.57 1.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.625 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.567 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.8 t -71.13 80.12 0.69 Allowed 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -176.71 -161.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.087 -178.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 48.04 -108.26 0.33 Allowed Glycine 0 N--CA 1.453 -0.185 0 N-CA-C 115.702 1.041 . . . . 0.0 115.702 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.836 HG21 ' HB3' ' A' ' 30' ' ' PRO . 8.0 p -96.31 5.12 8.83 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.802 ' SG ' HD11 ' A' ' 29' ' ' LEU . 85.4 m -71.24 -18.5 62.45 Favored 'General case' 0 CA--C 1.5 -0.98 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 16.4 mmmt -83.93 -10.81 57.68 Favored 'General case' 0 N--CA 1.427 -1.596 0 CA-C-N 111.91 -2.404 . . . . 0.0 109.06 178.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.508 ' HB3' HG22 ' A' ' 54' ' ' VAL . 3.9 t70 -102.57 -53.47 2.87 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.12 -0.946 . . . . 0.0 111.653 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.751 HD12 ' HA ' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -71.4 -11.77 61.06 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 -178.126 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 88.21 76.7 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 124.86 1.264 . . . . 0.0 108.975 178.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.699 HD12 ' HB3' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -141.4 -85.33 0.19 Allowed 'General case' 0 N--CA 1.428 -1.536 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.355 -176.64 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.584 ' H ' ' HB3' ' A' ' 55' ' ' CYS . 18.0 t . . . . . 0 C--O 1.245 0.85 0 CA-C-O 118.326 -0.845 . . . . 0.0 109.956 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.229 0 CA-C-O 120.701 0.286 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.35 -21.13 23.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.445 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.458 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -150.66 -165.79 13.04 Favored Glycine 0 CA--C 1.5 -0.861 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.594 -179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 22.4 tptm -68.37 -6.5 24.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 122.667 1.222 . . . . 0.0 107.854 177.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.823 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 4.0 m -105.55 128.66 53.72 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 112.92 -1.945 . . . . 0.0 111.294 -177.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.64 ' OG ' ' HB3' ' A' ' 9' ' ' LYS . 22.8 p -102.47 -169.94 1.74 Allowed 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.6 p -62.57 -58.68 6.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.293 0.568 . . . . 0.0 111.846 -179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -71.66 -24.98 61.94 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.398 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.64 ' HB3' ' OG ' ' A' ' 6' ' ' SER . 0.0 OUTLIER -86.34 -7.43 58.48 Favored 'General case' 0 N--CA 1.42 -1.925 0 CA-C-O 121.426 0.631 . . . . 0.0 109.755 179.637 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.653 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 66.0 tttm -73.97 -11.41 60.33 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-O 122.352 1.072 . . . . 0.0 108.381 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.87 -27.39 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -94.56 -15.1 24.39 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.596 -1.184 . . . . 0.0 113.551 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.493 ' O ' HG22 ' A' ' 17' ' ' ILE . 19.4 p -69.77 -22.21 63.36 Favored 'General case' 0 CA--C 1.511 -0.52 0 C-N-CA 119.656 -0.818 . . . . 0.0 110.409 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.6 -44.52 90.34 Favored 'General case' 0 C--O 1.215 -0.752 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.065 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.47 -29.88 69.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.074 0.464 . . . . 0.0 110.306 178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -75.04 -55.34 5.84 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.809 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.691 HG13 ' CD1' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -78.26 -25.17 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -178.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.416 ' HA ' HG22 ' A' ' 21' ' ' VAL . . . -52.0 -37.35 52.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 117.892 0.314 . . . . 0.0 111.144 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.8 -27.18 72.76 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.8 178.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -82.95 -36.19 25.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 111.435 0.161 . . . . 0.0 111.435 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.031 HG12 HG11 ' A' ' 32' ' ' VAL . 34.7 m -69.69 -38.6 76.66 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.82 -24.9 54.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 114.619 -1.173 . . . . 0.0 110.083 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -67.48 -29.28 68.68 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.027 178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.37 -48.7 3.5 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.089 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.37 -29.84 0.7 Allowed Glycine 0 N--CA 1.449 -0.448 0 N-CA-C 112.126 -0.39 . . . . 0.0 112.126 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . -171.95 -160.84 21.39 Favored Glycine 0 N--CA 1.452 -0.254 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG22 ' O ' ' A' ' 27' ' ' ILE . 11.6 mm -66.0 76.95 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.616 1.198 . . . . 0.0 111.941 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -104.63 79.22 1.53 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 103.642 -2.725 . . . . 0.0 103.642 176.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.998 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -41.56 -42.68 5.14 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -174.136 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.894 ' HG3' HG11 ' A' ' 54' ' ' VAL . 3.0 Cg_endo -72.9 -21.27 21.29 Favored 'Trans proline' 0 C--N 1.353 0.795 0 CA-C-N 121.578 1.599 . . . . 0.0 111.938 178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 8.9 t -88.73 -49.38 6.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.488 -0.778 . . . . 0.0 112.554 -178.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.031 HG11 HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -64.78 -27.05 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.082 -178.706 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.039 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -75.78 10.02 2.02 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 179.409 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.35 -26.94 16.34 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -110.08 -41.35 4.47 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.749 -1.114 . . . . 0.0 110.009 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.861 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.7 tp -71.27 -19.32 62.36 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.645 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 0.9 OUTLIER -58.25 -26.65 63.17 Favored 'General case' 0 C--N 1.313 -1.002 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.316 -176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -101.51 38.67 1.56 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.058 0.456 . . . . 0.0 110.099 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -98.49 44.41 1.03 Allowed 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.536 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 63.35 11.64 5.63 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 121.766 0.793 . . . . 0.0 109.545 -179.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 79.42 53.03 4.54 Favored Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.825 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.08 14.69 14.09 Favored 'General case' 0 CA--C 1.5 -0.949 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -68.78 -24.94 64.48 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 177.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.9 t -62.18 -24.28 67.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 114.017 -1.447 . . . . 0.0 109.125 176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.823 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 9.9 t -79.76 -42.66 24.04 Favored 'General case' 0 CA--C 1.511 -0.551 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.998 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.7 t80 -55.03 -61.2 2.47 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 113.352 -1.749 . . . . 0.0 111.049 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.707 ' CB ' HD12 ' A' ' 60' ' ' LEU . 4.7 t -89.95 49.63 1.75 Allowed 'General case' 0 C--O 1.232 0.176 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -91.57 -48.53 6.8 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -70.86 -56.42 6.32 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.122 179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.658 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -86.19 47.56 1.48 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.77 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' O ' ' SG ' ' A' ' 51' ' ' CYS . 2.0 t -74.8 73.56 2.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.455 178.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -170.82 176.73 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.23 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.27 -108.79 1.94 Allowed Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.521 -0.763 . . . . 0.0 114.578 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.894 HG11 ' HG3' ' A' ' 30' ' ' PRO . 5.0 p -84.26 -4.1 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.724 0 N-CA-C 111.404 0.15 . . . . 0.0 111.404 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.675 ' HA ' HD21 ' A' ' 58' ' ' LEU . 4.3 t -62.17 -15.21 44.58 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.629 0.728 . . . . 0.0 109.243 178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 24.9 tttt -85.18 -28.1 25.69 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.014 177.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -47.75 15.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.06 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.039 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -73.01 -7.53 51.64 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 120.007 -0.677 . . . . 0.0 110.558 179.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.45 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.1 OUTLIER 66.38 62.22 0.56 Allowed 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 115.547 1.684 . . . . 0.0 115.547 175.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.997 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.5 mt -120.1 -72.31 0.69 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.169 0.509 . . . . 0.0 110.826 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 41.3 t . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.412 -178.467 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 110.474 -0.195 . . . . 0.0 110.474 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 63.9 mtt -79.02 73.25 5.57 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.964 0.411 . . . . 0.0 110.045 179.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.513 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 80.63 -161.97 44.87 Favored Glycine 0 CA--C 1.495 -1.205 0 C-N-CA 119.547 -1.311 . . . . 0.0 111.126 -178.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -83.03 16.24 2.43 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.736 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 34.7 m -112.07 99.25 7.93 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 113.67 -1.605 . . . . 0.0 111.555 -177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.599 ' H ' ' HB2' ' A' ' 9' ' ' LYS . 33.7 p -80.82 -167.86 1.55 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 178.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.638 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -52.92 -59.78 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.165 0.507 . . . . 0.0 111.843 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.638 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -73.71 -23.66 59.81 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.578 -179.354 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.599 ' HB2' ' H ' ' A' ' 6' ' ' SER . 38.9 mttm -77.61 -15.24 59.34 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.278 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.666 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 14.9 mtpp -75.8 -12.64 60.21 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 121.49 0.662 . . . . 0.0 109.514 177.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -91.61 -25.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -86.45 -31.81 21.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.203 -1.362 . . . . 0.0 112.476 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.666 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.7 p -63.12 -36.27 83.05 Favored 'General case' 0 CA--C 1.504 -0.807 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.84 -179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.568 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -60.25 -32.68 71.39 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.533 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.03 -40.51 15.71 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 121.19 0.519 . . . . 0.0 110.078 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.7 -53.77 54.11 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.21 -0.905 . . . . 0.0 111.473 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.734 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -74.39 -29.54 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 119.871 -0.732 . . . . 0.0 111.403 -179.636 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.23 -38.2 51.15 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 120.784 0.326 . . . . 0.0 110.622 178.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -69.14 -25.4 75.46 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.952 178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -79.15 -39.83 32.48 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 111.415 0.154 . . . . 0.0 111.415 179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.979 HG12 HG11 ' A' ' 32' ' ' VAL . 17.9 m -68.23 -37.55 78.23 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.659 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.89 -25.99 61.54 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.238 -1.346 . . . . 0.0 109.554 178.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -72.01 -33.6 68.2 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.895 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.486 ' HB3' ' OD1' ' A' ' 28' ' ' ASP . 1.7 t -100.03 -64.99 0.99 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 120.753 -0.379 . . . . 0.0 111.678 179.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 177.73 -38.39 0.09 OUTLIER Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.929 -1.129 . . . . 0.0 114.116 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 167.02 97.86 0.12 Allowed Glycine 0 C--N 1.331 0.294 0 C-N-CA 120.039 -1.077 . . . . 0.0 113.3 -179.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.651 HG22 ' O ' ' A' ' 27' ' ' ILE . 24.8 mm 46.02 47.08 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 123.116 1.436 . . . . 0.0 113.05 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.583 ' HB2' ' HB3' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -87.03 84.0 7.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 102.431 -3.174 . . . . 0.0 102.431 174.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.105 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -43.82 -44.55 16.09 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 115.775 1.768 . . . . 0.0 115.775 -173.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.686 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 73.5 Cg_endo -75.29 -8.92 20.14 Favored 'Trans proline' 0 C--N 1.352 0.717 0 CA-C-N 121.35 1.518 . . . . 0.0 112.127 178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.583 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 1.7 t -99.88 -47.08 5.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.565 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.979 HG11 HG12 ' A' ' 21' ' ' VAL . 1.2 m -66.45 -32.24 57.16 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.602 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.799 ' O ' ' HB2' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -69.15 -6.47 28.89 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.097 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.98 -23.37 26.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.233 0.539 . . . . 0.0 109.668 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -109.35 -40.37 4.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.011 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.741 HD21 ' HA ' ' A' ' 43' ' ' ALA . 16.1 tp -68.52 -22.31 64.52 Favored 'General case' 0 CA--C 1.51 -0.581 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.094 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.799 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 8.7 tmtt? -60.55 -15.18 24.98 Favored 'General case' 0 C--N 1.317 -0.824 0 C-N-CA 119.986 -0.686 . . . . 0.0 111.153 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.42 -12.8 61.69 Favored 'General case' 0 C--O 1.232 0.15 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.97 155.32 38.9 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.238 -0.892 . . . . 0.0 109.298 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 57.1 mp0 -60.79 -21.17 62.8 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.629 0.728 . . . . 0.0 109.537 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 142.92 43.89 0.05 OUTLIER Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 114.714 -1.13 . . . . 0.0 111.434 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -97.0 11.38 36.28 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.458 -0.897 . . . . 0.0 109.033 179.339 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.913 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -63.17 -34.09 76.89 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.694 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 55.5 m -54.88 -20.06 7.98 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.194 -1.366 . . . . 0.0 110.821 178.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.736 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.4 t -85.69 -47.68 9.56 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 176.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.105 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.3 t80 -51.63 -67.28 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 113.087 -1.87 . . . . 0.0 112.809 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.413 ' HB2' ' CD2' ' A' ' 46' ' ' PHE . 11.7 t -92.38 11.32 26.48 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 -175.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.694 ' HB2' ' O ' ' A' ' 44' ' ' SER . 18.6 tp10 -64.2 -38.12 89.91 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.75 1.159 . . . . 0.0 109.864 178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -79.23 -16.15 56.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.409 179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.466 ' HE1' HD12 ' A' ' 27' ' ' ILE . 0.0 OUTLIER -116.86 32.92 5.88 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.183 -179.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.609 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 23.6 m -69.65 71.61 0.34 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.636 0.731 . . . . 0.0 112.725 -178.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 10.0 p-80 -164.86 173.53 11.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.815 -1.084 . . . . 0.0 108.768 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 63.75 -107.22 1.65 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.687 -0.768 . . . . 0.0 113.62 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.04 HG13 HD13 ' A' ' 58' ' ' LEU . 1.6 p -94.12 -3.45 10.69 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 CA-C-N 116.746 0.273 . . . . 0.0 111.448 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.697 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.7 t -61.21 -19.09 61.22 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.3 ttmm -81.9 -32.79 30.78 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.532 ' HB3' HG22 ' A' ' 54' ' ' VAL . 13.5 t0 -73.76 -39.98 63.82 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 176.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.04 HD13 HG13 ' A' ' 54' ' ' VAL . 1.6 mp -52.93 -50.34 64.19 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 113.091 -1.868 . . . . 0.0 107.512 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t60 66.05 75.21 0.34 Allowed 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.624 178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.913 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -146.74 -7.04 0.51 Allowed 'General case' 0 N--CA 1.431 -1.406 0 CA-C-N 114.544 -1.207 . . . . 0.0 110.792 -175.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.198 -0.906 . . . . 0.0 109.651 177.732 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 120.812 0.339 . . . . 0.0 110.83 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 16.7 ptm -80.31 61.98 4.28 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.861 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 85.84 170.53 47.14 Favored Glycine 0 CA--C 1.498 -1.015 0 C-N-CA 119.833 -1.175 . . . . 0.0 112.503 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 tmtt? -82.22 -1.18 48.38 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 106.273 -1.751 . . . . 0.0 106.273 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 20.6 m -122.33 82.2 1.94 Allowed 'General case' 0 N--CA 1.437 -1.123 0 CA-C-N 113.057 -1.883 . . . . 0.0 109.593 -178.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.501 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 8.2 m -62.35 -170.92 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.498 0 O-C-N 123.126 0.266 . . . . 0.0 111.281 -179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 m -53.05 -50.41 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.59 -33.96 47.15 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.501 ' HB2' ' N ' ' A' ' 6' ' ' SER . 27.4 mtpp -73.42 -15.09 61.36 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.069 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.733 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 ttmp? -85.03 -6.58 59.32 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-O 121.446 0.641 . . . . 0.0 109.749 179.411 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -94.57 -27.84 4.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.698 0.761 . . . . 0.0 109.458 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -91.44 -16.5 27.24 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.861 -1.063 . . . . 0.0 113.222 -178.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.733 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 0.7 OUTLIER -69.12 -24.56 64.12 Favored 'General case' 0 CA--C 1.504 -0.805 0 C-N-CA 120.421 -0.512 . . . . 0.0 111.165 -179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.677 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.74 -25.57 67.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.66 -32.64 15.39 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.211 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 13' ' ' CYS . . . -64.81 -54.34 32.64 Favored 'General case' 0 CA--C 1.514 -0.432 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.446 178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.805 ' HA ' HD13 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -74.82 -26.18 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.915 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.677 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -47.21 -42.7 20.59 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.954 0.354 . . . . 0.0 111.954 178.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.18 -19.14 63.59 Favored Glycine 0 CA--C 1.52 0.374 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.481 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.99 -40.51 12.95 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.301 0.241 . . . . 0.0 111.082 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.012 HG12 HG11 ' A' ' 32' ' ' VAL . 25.5 m -67.53 -37.74 79.35 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.737 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.009 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.52 -27.06 62.25 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.714 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -66.07 -26.49 67.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.519 178.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -108.49 -29.69 8.66 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.882 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 128.14 -18.58 5.84 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.912 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.626 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . -176.71 -166.78 34.33 Favored Glycine 0 N--CA 1.45 -0.43 0 N-CA-C 110.56 -1.016 . . . . 0.0 110.56 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.91 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -65.83 68.68 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 122.65 1.214 . . . . 0.0 111.481 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' O ' HG13 ' A' ' 32' ' ' VAL . 23.3 m-20 -94.84 74.86 3.6 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 102.523 -3.14 . . . . 0.0 102.523 175.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.948 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 2.6 tt -42.59 -42.09 6.56 Favored Pre-proline 0 CA--C 1.552 1.054 0 CA-C-N 113.942 -1.481 . . . . 0.0 114.302 -174.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.93 ' HB3' HG11 ' A' ' 54' ' ' VAL . 37.5 Cg_endo -68.09 -27.95 35.24 Favored 'Trans proline' 0 C--N 1.361 1.214 0 CA-C-N 121.178 1.456 . . . . 0.0 112.27 177.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 9.0 t -82.02 -47.12 13.03 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 114.721 -1.127 . . . . 0.0 113.067 -177.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.012 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -63.67 -28.06 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.02 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.99 15.73 0.19 Allowed 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -103.9 -38.81 6.86 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -94.85 -39.47 10.23 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.803 -1.089 . . . . 0.0 110.049 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.865 HD21 ' HA ' ' A' ' 43' ' ' ALA . 19.8 tp -73.02 -23.59 60.64 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.903 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.658 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 13.1 ttpp -65.47 -11.04 39.37 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 118.539 -1.264 . . . . 0.0 110.801 -177.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.24 -10.46 59.43 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 177.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.5 165.09 5.12 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.989 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -78.85 17.65 0.7 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.29 0.567 . . . . 0.0 110.8 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 104.85 39.98 2.23 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.593 -0.73 . . . . 0.0 113.632 178.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -106.35 17.26 23.67 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-N 118.46 1.13 . . . . 0.0 109.361 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.865 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -65.36 -28.37 69.23 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.578 177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.521 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -55.08 -35.59 64.73 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 114.039 -1.437 . . . . 0.0 109.472 177.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.593 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 48.9 t -70.03 -47.16 63.19 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.335 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.948 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.6 t80 -54.52 -62.12 1.86 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.641 179.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.574 ' SG ' HD11 ' A' ' 29' ' ' LEU . 0.1 OUTLIER -76.14 14.59 0.69 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 179.128 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' HB2' ' O ' ' A' ' 44' ' ' SER . 6.8 tp10 -81.6 -41.79 21.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.468 0.651 . . . . 0.0 109.3 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -76.92 -29.62 55.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.1 -0.955 . . . . 0.0 110.774 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.742 ' ND1' HD12 ' A' ' 29' ' ' LEU . 6.7 p80 -133.08 66.5 1.56 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.416 0.627 . . . . 0.0 112.169 -179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 44.8 t -83.42 76.72 9.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.755 178.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 35.7 p-80 -163.29 -167.56 1.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.012 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 60.17 -109.7 2.44 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.77 -0.65 . . . . 0.0 113.625 178.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.978 HG13 HD13 ' A' ' 58' ' ' LEU . 2.1 p -102.12 8.77 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 N-CA-C 111.337 0.125 . . . . 0.0 111.337 -178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 9.4 t -65.39 -21.73 66.71 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.5 tmtp? -74.99 -40.43 60.69 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 113.27 -1.786 . . . . 0.0 109.286 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -26.17 45.74 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.02 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.0 OUTLIER -58.98 -56.88 16.59 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 113.993 -1.458 . . . . 0.0 107.314 178.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.658 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 22.2 m-70 91.04 60.79 0.0 OUTLIER 'General case' 0 CA--C 1.488 -1.407 0 CA-C-O 122.882 1.325 . . . . 0.0 109.154 177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.691 HD23 ' C ' ' A' ' 60' ' ' LEU . 0.3 OUTLIER -146.99 -40.85 0.19 Allowed 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 112.233 -2.258 . . . . 0.0 108.779 -176.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.292 -0.861 . . . . 0.0 109.4 179.242 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.513 0.197 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 32.3 mtm 58.2 -100.59 0.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 O-C-N 123.857 0.723 . . . . 0.0 111.078 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 142.89 -176.77 22.3 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.191 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.435 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 23.7 ttmm -62.01 -22.08 65.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.968 0.889 . . . . 0.0 109.198 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.551 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.3 m -74.59 90.64 2.27 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.187 -1.369 . . . . 0.0 110.446 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.533 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 25.7 m -73.25 -160.36 0.08 Allowed 'General case' 0 C--O 1.224 -0.263 0 O-C-N 123.171 0.294 . . . . 0.0 111.09 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.658 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.71 -60.74 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.658 ' H ' HG13 ' A' ' 7' ' ' VAL . 4.5 pp -76.09 -24.72 55.03 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.572 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.533 ' HB2' ' N ' ' A' ' 6' ' ' SER . 74.7 mttt -80.49 -11.2 59.7 Favored 'General case' 0 N--CA 1.451 -0.423 0 O-C-N 122.067 -0.395 . . . . 0.0 110.438 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 tppt? -71.66 -18.12 62.21 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 177.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.46 -24.95 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 114.607 -1.179 . . . . 0.0 108.398 178.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.268 -1.333 . . . . 0.0 113.555 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.551 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 0.8 OUTLIER -67.86 -14.6 63.09 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.522 179.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.596 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -77.13 -44.48 30.24 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.43 -27.31 67.73 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.382 0.61 . . . . 0.0 109.71 178.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -82.34 -58.05 3.1 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 115.184 -0.916 . . . . 0.0 112.055 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.007 HD11 HG21 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -97.93 -40.77 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -177.152 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.54 -26.01 12.03 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 119.645 1.111 . . . . 0.0 110.281 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -83.51 -25.6 46.3 Favored Glycine 0 CA--C 1.527 0.843 0 N-CA-C 111.259 -0.737 . . . . 0.0 111.259 177.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -76.37 -38.65 55.48 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 122.508 0.323 . . . . 0.0 111.102 179.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.003 HG12 HG11 ' A' ' 32' ' ' VAL . 35.3 m -67.96 -39.89 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.537 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.52 -23.32 57.87 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.891 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -69.69 -25.66 63.99 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.717 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 29.8 p -120.65 -23.06 6.13 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.9 -9.71 4.22 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 118.815 -1.659 . . . . 0.0 114.441 178.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.528 ' C ' ' HB ' ' A' ' 21' ' ' VAL . . . 161.65 -167.42 36.43 Favored Glycine 0 CA--C 1.504 -0.622 0 C-N-CA 119.685 -1.245 . . . . 0.0 112.496 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.644 HD13 HG11 ' A' ' 21' ' ' VAL . 14.2 mm -69.94 76.08 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 122.735 1.255 . . . . 0.0 111.563 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.657 ' O ' HG13 ' A' ' 32' ' ' VAL . 34.5 m-20 -103.44 84.31 2.29 Favored 'General case' 0 N--CA 1.429 -1.51 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 176.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.065 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -48.45 -43.14 59.33 Favored Pre-proline 0 N--CA 1.443 -0.783 0 N-CA-C 115.091 1.515 . . . . 0.0 115.091 -173.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.561 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 38.4 Cg_endo -67.03 -24.96 44.62 Favored 'Trans proline' 0 C--N 1.352 0.73 0 CA-C-N 121.145 1.445 . . . . 0.0 111.108 177.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -77.62 -62.26 1.72 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.007 HG21 HD11 ' A' ' 17' ' ' ILE . 0.8 OUTLIER -63.52 -38.86 83.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 113.005 -173.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.957 HD22 ' HB2' ' A' ' 58' ' ' LEU . 2.5 tt -69.86 -16.36 63.24 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 120.349 -0.54 . . . . 0.0 111.956 -177.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.03 -28.99 68.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.248 0.547 . . . . 0.0 109.798 177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.57 -34.15 7.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.606 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.85 ' HB3' ' HA ' ' A' ' 33' ' ' LEU . 22.3 tp -66.8 -21.97 66.03 Favored 'General case' 0 CA--C 1.503 -0.837 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.022 179.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.739 ' HG2' ' CD2' ' A' ' 33' ' ' LEU . 1.4 mmtp -63.34 -13.28 37.29 Favored 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.703 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -65.63 -17.42 64.58 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.16 150.23 46.12 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.96 177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -63.79 -11.54 27.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.323 0.583 . . . . 0.0 110.544 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 135.34 51.08 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.53 179.348 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.95 14.34 19.7 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-O 121.695 0.76 . . . . 0.0 109.27 179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.809 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -67.08 -20.57 65.83 Favored 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 114.103 -1.408 . . . . 0.0 107.727 176.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.627 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 50.5 p -56.58 -36.95 69.94 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 113.579 -1.646 . . . . 0.0 109.684 177.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.508 ' HA ' ' OE2' ' A' ' 48' ' ' GLU . 19.5 t -71.51 -31.92 67.62 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.72 179.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.065 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.7 t80 -71.27 -65.28 0.77 Allowed 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.625 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.749 ' CB ' HD12 ' A' ' 60' ' ' LEU . 5.2 t -88.25 32.63 0.76 Allowed 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.627 ' HB3' ' O ' ' A' ' 44' ' ' SER . 15.4 pt-20 -95.33 -2.73 48.64 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.406 -0.809 . . . . 0.0 110.113 178.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -108.37 -26.6 10.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.958 179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.604 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 8.0 p80 -132.67 49.06 2.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.802 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 47' ' ' CYS . 20.8 p -81.92 80.42 8.2 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 122.19 0.995 . . . . 0.0 111.804 -179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -152.86 175.41 12.93 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.344 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 55.19 -101.56 0.12 Allowed Glycine 0 CA--C 1.52 0.403 0 N-CA-C 114.691 0.636 . . . . 0.0 114.691 178.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.681 ' O ' HD13 ' A' ' 58' ' ' LEU . 4.4 p -85.83 -7.02 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 111.622 0.23 . . . . 0.0 111.622 -178.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.689 ' HA ' ' CD2' ' A' ' 58' ' ' LEU . 4.2 t -65.61 -12.51 53.91 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.416 0.627 . . . . 0.0 109.373 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm -85.42 -22.16 28.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -85.65 -46.34 10.85 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.834 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.076 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -74.18 -6.62 48.83 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 120.032 -0.667 . . . . 0.0 111.286 -179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.644 ' O ' HD23 ' A' ' 60' ' ' LEU . 1.4 t-80 65.44 65.28 0.57 Allowed 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.076 ' HG ' HD23 ' A' ' 58' ' ' LEU . 21.6 mt -125.43 -60.94 1.3 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.859 0.362 . . . . 0.0 110.923 177.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 51' ' ' CYS . 2.9 t . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.444 -0.788 . . . . 0.0 109.942 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.26 0 CA-C-O 120.681 0.277 . . . . 0.0 110.665 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.613 ' HG3' ' H ' ' A' ' 3' ' ' GLY . 13.7 ptp -108.2 -61.21 1.62 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.847 0.356 . . . . 0.0 110.766 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.613 ' H ' ' HG3' ' A' ' 2' ' ' MET . . . -116.42 -159.01 11.58 Favored Glycine 0 CA--C 1.496 -1.147 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.909 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 32.6 tttp -71.96 -7.66 49.95 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.615 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 69.7 m -105.98 129.16 54.16 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-N 112.27 -2.241 . . . . 0.0 110.513 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.742 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 30.5 p -77.78 -167.31 0.94 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 178.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.615 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.1 p -55.84 -58.02 6.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.307 0.575 . . . . 0.0 111.002 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.615 ' H ' HG13 ' A' ' 7' ' ' VAL . 3.9 pp -69.94 -25.19 63.53 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.476 -0.784 . . . . 0.0 110.904 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.742 ' HB2' ' N ' ' A' ' 6' ' ' SER . 14.8 mmtp -77.23 -8.9 58.34 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.869 0.366 . . . . 0.0 110.1 178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.466 ' HB3' ' O ' ' A' ' 7' ' ' VAL . 41.0 tptt -74.57 -15.6 60.84 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.96 -21.75 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.129 0 CA-C-N 114.621 -1.172 . . . . 0.0 107.979 177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.56 -18.69 61.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 113.745 -1.571 . . . . 0.0 113.482 -178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 45' ' ' CYS . 0.0 OUTLIER -66.48 -26.38 67.16 Favored 'General case' 0 CA--C 1.512 -0.481 0 C-N-CA 119.243 -0.983 . . . . 0.0 109.223 179.307 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.709 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -81.75 -23.25 36.77 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 121.647 0.737 . . . . 0.0 109.905 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -87.02 -23.62 24.93 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.263 179.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -106.18 -52.73 2.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.766 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.103 HG12 HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -89.19 -39.71 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -177.704 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -56.55 -22.63 34.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 118.719 0.69 . . . . 0.0 109.492 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -89.32 -32.51 10.38 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.509 177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.926 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -76.22 -42.17 46.91 Favored 'General case' 0 C--N 1.341 0.226 0 CA-C-N 116.847 0.324 . . . . 0.0 111.231 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.058 HG12 HG11 ' A' ' 32' ' ' VAL . 13.0 m -64.47 -41.68 93.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.8 -32.97 72.3 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 113.988 -1.46 . . . . 0.0 110.477 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.6 -22.21 66.65 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.297 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 5.7 t -100.42 -43.77 6.12 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.205 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.84 40.14 0.27 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 120.31 -0.947 . . . . 0.0 112.837 179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 122.27 -170.76 15.18 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.671 HD13 HG11 ' A' ' 21' ' ' VAL . 20.2 mm -75.15 77.83 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 122.324 1.059 . . . . 0.0 112.308 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.714 ' O ' HG13 ' A' ' 32' ' ' VAL . 7.0 t70 -102.02 84.57 2.53 Favored 'General case' 0 CA--C 1.504 -0.82 0 N-CA-C 102.182 -3.266 . . . . 0.0 102.182 174.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.978 HD23 HG12 ' A' ' 54' ' ' VAL 0.256 0.4 OUTLIER -52.75 -39.45 68.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.463 -1.244 . . . . 0.0 113.449 -174.342 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.007 ' HB3' HG11 ' A' ' 54' ' ' VAL . 55.0 Cg_endo -72.11 -17.4 28.15 Favored 'Trans proline' 0 C--N 1.364 1.386 0 C-N-CA 121.433 1.422 . . . . 0.0 112.162 176.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.635 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 7.0 t -88.36 -49.33 7.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.836 -177.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.058 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -64.13 -35.19 73.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 113.562 0.949 . . . . 0.0 113.562 -176.229 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.038 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -74.52 16.93 0.23 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.86 -35.31 12.11 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.0 -38.12 7.1 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 114.673 -1.149 . . . . 0.0 109.62 178.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.103 HD22 HG12 ' A' ' 17' ' ' ILE . 11.2 tp -66.85 -23.42 66.02 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.871 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.711 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 38.2 tttp -62.12 -18.84 62.08 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.924 -176.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -84.49 7.26 20.47 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.357 178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.439 ' C ' ' H ' ' A' ' 41' ' ' GLY . . . -64.32 166.29 8.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.503 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.424 ' HG2' ' H ' ' A' ' 40' ' ' GLU . 15.0 pt-20 -79.66 38.15 0.37 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.458 0.647 . . . . 0.0 109.385 178.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 39' ' ' ALA . . . 74.39 72.0 1.07 Allowed Glycine 0 N--CA 1.439 -1.138 0 N-CA-C 110.703 -0.959 . . . . 0.0 110.703 -178.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.84 16.74 0.98 Allowed 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 120.162 -0.615 . . . . 0.0 110.271 -179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -60.75 -37.17 80.91 Favored 'General case' 0 N--CA 1.441 -0.925 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.025 178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 38.6 p -49.52 -41.39 40.88 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.801 178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.615 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -52.41 -45.55 65.97 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-O 121.912 0.863 . . . . 0.0 109.927 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.916 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 0.4 OUTLIER -66.43 -60.83 2.39 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 113.985 -1.462 . . . . 0.0 110.55 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.887 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 3.6 t -77.97 -1.21 30.89 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 116.101 1.889 . . . . 0.0 116.101 -177.066 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 44' ' ' SER . 11.2 mt-10 -61.18 -30.08 70.2 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.393 1.451 . . . . 0.0 111.26 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -83.91 -30.51 26.29 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.422 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 5.4 p80 -133.75 56.6 1.84 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.887 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.1 m -77.9 66.08 3.47 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 121.197 0.522 . . . . 0.0 111.066 179.252 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.428 ' CE1' ' HB2' ' A' ' 50' ' ' HIS . 17.0 p-80 -147.03 -169.7 3.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.58 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.84 -115.09 7.56 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.696 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.007 HG11 ' HB3' ' A' ' 30' ' ' PRO . 1.4 p -98.54 13.53 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.379 0 O-C-N 122.83 -0.218 . . . . 0.0 110.593 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.836 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 8.8 t -74.26 -17.06 60.92 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 178.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 44.4 mmtt -75.35 -34.18 61.15 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 112.012 -2.358 . . . . 0.0 108.704 177.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.491 ' HB3' HG22 ' A' ' 54' ' ' VAL . 2.5 t70 -86.88 -34.69 19.34 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 177.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.038 ' HG ' HD22 ' A' ' 33' ' ' LEU . 1.1 tp -52.54 -45.98 66.57 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 113.028 -1.897 . . . . 0.0 109.082 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 63.24 77.06 0.34 Allowed 'General case' 0 CA--C 1.511 -0.532 0 CA-C-N 115.377 -0.829 . . . . 0.0 109.864 179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.012 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -141.4 -13.47 0.89 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.466 -177.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.664 ' N ' HD23 ' A' ' 60' ' ' LEU . 29.8 p . . . . . 0 C--O 1.244 0.801 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.435 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.449 ' CB ' ' HG3' ' A' ' 48' ' ' GLU . . . . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.735 0.302 . . . . 0.0 110.783 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 31.2 ttp -86.49 -93.61 0.09 Allowed 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.41 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 76.15 -162.3 52.51 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 119.668 -1.253 . . . . 0.0 113.487 178.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 41' ' ' GLY . 18.7 tptm -77.58 -0.48 26.55 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 122.75 1.262 . . . . 0.0 108.38 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.733 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 35.8 m -102.08 91.08 4.17 Favored 'General case' 0 N--CA 1.431 -1.387 0 CA-C-N 113.068 -1.878 . . . . 0.0 111.973 -177.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.529 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 59.1 p -71.8 -176.31 1.63 Allowed 'General case' 0 C--O 1.225 -0.231 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.644 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.8 p -47.99 -62.45 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -179.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.644 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -68.75 -31.33 70.3 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.928 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.529 ' HB3' ' N ' ' A' ' 6' ' ' SER . 8.3 tppt? -69.27 -19.2 63.92 Favored 'General case' 0 N--CA 1.417 -2.11 0 C-N-CA 122.835 0.454 . . . . 0.0 110.652 179.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.605 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 32.1 mtmt -73.14 -20.96 60.81 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-O 121.256 0.55 . . . . 0.0 109.994 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.67 -24.09 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.87 -12.43 22.14 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.169 -1.378 . . . . 0.0 113.663 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.605 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 1.6 p -71.78 -36.42 70.34 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 119.328 0.967 . . . . 0.0 110.557 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -64.8 -28.39 69.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.59 -28.78 33.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.224 177.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -69.52 -57.73 4.85 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.687 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 36' ' ' LEU . 0.0 OUTLIER -69.26 -21.49 25.12 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.035 0 C-N-CA 120.366 -0.534 . . . . 0.0 111.286 178.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.565 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -51.99 -37.41 53.05 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.167 178.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -70.45 -23.27 77.66 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.265 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 23' ' ' ALA . . . -88.78 -40.39 13.23 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 122.924 -0.163 . . . . 0.0 111.033 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.027 HG12 HG11 ' A' ' 32' ' ' VAL . 35.7 m -66.65 -37.54 79.74 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.774 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.83 -24.92 62.68 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.732 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 20' ' ' ALA . . . -70.13 -35.09 73.83 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.124 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.8 -35.61 9.72 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 56.57 0.28 Allowed Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.196 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.569 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 110.79 -179.04 20.01 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.285 -0.726 . . . . 0.0 111.285 -179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.62 HD13 HG11 ' A' ' 21' ' ' VAL . 12.5 mm -65.11 84.68 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-O 121.997 0.903 . . . . 0.0 111.817 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.531 ' O ' HG13 ' A' ' 32' ' ' VAL . 39.9 t0 -105.77 78.79 1.37 Allowed 'General case' 0 CA--C 1.5 -0.943 0 N-CA-C 102.356 -3.201 . . . . 0.0 102.356 175.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.066 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 6.1 tt -45.78 -39.62 12.25 Favored Pre-proline 0 CA--C 1.55 0.949 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -174.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.723 ' HB3' HG11 ' A' ' 54' ' ' VAL . 59.1 Cg_endo -74.73 -14.35 21.85 Favored 'Trans proline' 0 C--N 1.362 1.247 0 CA-C-N 121.343 1.515 . . . . 0.0 112.08 176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 3.8 t -94.49 -50.24 5.3 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.195 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.027 HG11 HG12 ' A' ' 21' ' ' VAL . 1.4 m -61.8 -30.0 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 1.033 HD22 ' HB2' ' A' ' 58' ' ' LEU . 0.1 OUTLIER -78.14 27.5 0.19 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 112.699 0.629 . . . . 0.0 112.699 -179.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.57 -36.87 6.08 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 176.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -102.72 -40.05 6.76 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.577 177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.924 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.3 tp -70.92 -20.46 62.48 Favored 'General case' 0 CA--C 1.509 -0.596 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.546 178.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 1.9 tmtp? -67.32 -23.04 65.59 Favored 'General case' 0 C--N 1.311 -1.087 0 C-N-CA 118.497 -1.281 . . . . 0.0 108.908 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -96.1 14.01 25.31 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.198 178.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -74.84 -164.7 0.31 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.824 -0.625 . . . . 0.0 109.905 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -82.81 40.81 0.7 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.459 0.647 . . . . 0.0 109.458 178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 4' ' ' LYS . . . 56.14 42.97 88.7 Favored Glycine 0 C--O 1.223 -0.559 0 CA-C-N 114.998 -1.001 . . . . 0.0 112.462 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.565 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -114.3 19.21 16.47 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.61 -0.935 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.924 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -69.7 -25.6 63.95 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -61.61 -23.38 65.99 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 113.572 -1.649 . . . . 0.0 109.755 178.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.733 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 52.9 t -83.81 -43.95 14.87 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 115.404 -0.816 . . . . 0.0 108.935 177.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.066 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 5.3 t80 -48.93 -63.43 1.1 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.796 178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.658 ' CB ' HD12 ' A' ' 60' ' ' LEU . 53.7 t -82.26 69.02 8.91 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.781 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' HG3' ' CB ' ' A' ' 1' ' ' ALA . 25.8 tt0 -108.25 -66.37 1.05 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 178.097 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.52 -37.53 80.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.387 178.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.701 ' CD2' ' H ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -94.5 47.36 1.18 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.032 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.514 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 29.6 t -75.44 74.79 2.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.052 178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -176.04 -170.33 0.37 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.314 -178.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 62.85 -111.7 4.31 Favored Glycine 0 N--CA 1.451 -0.32 0 CA-C-N 115.381 -0.827 . . . . 0.0 114.619 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.6 p -94.58 -1.37 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.956 0 CA-C-O 120.519 0.2 . . . . 0.0 110.804 -178.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.607 ' HA ' HD21 ' A' ' 58' ' ' LEU . 29.1 t -62.52 -19.58 63.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.854 0.835 . . . . 0.0 108.812 178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -74.84 -28.74 60.8 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.479 -1.237 . . . . 0.0 108.494 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB3' HG22 ' A' ' 54' ' ' VAL . 7.2 t70 -78.89 -55.72 4.93 Favored 'General case' 0 N--CA 1.454 -0.227 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.824 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.033 ' HB2' HD22 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -66.42 -27.43 67.83 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.937 -178.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.603 ' O ' HD23 ' A' ' 60' ' ' LEU . 0.3 OUTLIER 84.84 80.39 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 176.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.867 HD11 HD11 ' A' ' 33' ' ' LEU . 35.1 mt -130.41 -75.95 0.53 Allowed 'General case' 0 CA--C 1.519 -0.242 0 CA-C-O 121.387 0.613 . . . . 0.0 110.105 177.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.1 t . . . . . 0 C--O 1.247 0.925 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.274 -179.435 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 121.086 0.47 . . . . 0.0 110.803 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 18.7 mmt -101.87 159.39 15.38 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 140.78 -166.08 26.0 Favored Glycine 0 CA--C 1.493 -1.281 0 C-N-CA 120.087 -1.054 . . . . 0.0 111.7 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.586 ' HE2' ' HA ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -61.16 -25.58 67.11 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 175.489 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.75 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 60.3 m -108.47 74.45 0.93 Allowed 'General case' 0 N--CA 1.432 -1.359 0 CA-C-N 111.503 -2.59 . . . . 0.0 109.999 179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.623 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 14.7 p -67.36 -174.89 0.43 Allowed 'General case' 0 C--O 1.221 -0.412 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.359 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.592 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.7 p -47.99 -58.54 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 112.086 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.8 pt? -72.24 -23.77 61.28 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.596 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.623 ' HB2' ' N ' ' A' ' 6' ' ' SER . 29.3 mmtp -80.24 -22.94 41.21 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-O 120.671 0.272 . . . . 0.0 110.633 179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.57 ' HG3' ' SG ' ' A' ' 45' ' ' CYS . 86.0 tttt -71.88 -23.06 61.44 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.828 0.823 . . . . 0.0 109.591 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.49 -25.8 17.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -97.45 -15.64 20.53 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.42 -1.264 . . . . 0.0 114.043 -178.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' O ' HG22 ' A' ' 17' ' ' ILE . 7.2 p -65.59 -34.74 78.93 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.656 1.117 . . . . 0.0 110.624 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.675 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.78 -28.26 69.33 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.156 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.0 -32.33 15.97 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.843 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -64.52 -53.41 48.5 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.075 179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.709 ' CD1' HG13 ' A' ' 21' ' ' VAL . 0.0 OUTLIER -75.53 -26.46 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.211 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.928 179.435 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.675 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -50.6 -40.89 53.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.195 178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.0 -21.99 71.98 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.28 179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.64 -41.62 17.59 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 122.279 0.231 . . . . 0.0 111.048 179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.039 HG12 HG11 ' A' ' 32' ' ' VAL . 34.4 m -68.45 -39.67 81.06 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.778 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 177.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.86 -23.47 65.19 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.551 177.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -77.74 -31.39 52.14 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.355 179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 8.3 t -99.63 -45.92 5.62 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.05 45.29 0.11 Allowed Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.281 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 115.39 -177.97 17.49 Favored Glycine 0 C--N 1.329 0.172 0 C-N-CA 120.755 -0.736 . . . . 0.0 111.713 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.747 HD13 HG11 ' A' ' 21' ' ' VAL . 15.5 mm -67.41 67.38 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 CA-C-O 122.698 1.237 . . . . 0.0 112.089 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.598 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.2 t0 -91.5 84.83 5.59 Favored 'General case' 0 CA--C 1.5 -0.979 0 N-CA-C 101.571 -3.492 . . . . 0.0 101.571 174.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.112 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -50.05 -41.47 64.29 Favored Pre-proline 0 N--CA 1.441 -0.921 0 CA-C-N 114.927 -1.033 . . . . 0.0 113.407 -173.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 1.032 ' HB3' HG11 ' A' ' 54' ' ' VAL . 60.8 Cg_endo -76.29 -3.04 13.33 Favored 'Trans proline' 0 C--N 1.362 1.268 0 CA-C-N 121.099 1.428 . . . . 0.0 112.15 176.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 2.0 t -105.44 -47.36 3.96 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -178.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.039 HG11 HG12 ' A' ' 21' ' ' VAL . 0.7 OUTLIER -63.36 -22.79 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.834 0 O-C-N 122.253 -0.279 . . . . 0.0 111.195 -178.011 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.848 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.4 OUTLIER -72.73 15.82 0.18 Allowed 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 179.404 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 32' ' ' VAL . . . -102.48 -49.82 3.76 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -86.46 -35.99 19.33 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.122 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.802 HD21 ' HA ' ' A' ' 43' ' ' ALA . 18.6 tp -74.04 -21.66 59.86 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 121.392 0.615 . . . . 0.0 110.589 179.263 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.617 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 53.1 tptt -55.49 -24.52 31.86 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.783 -177.066 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.33 -1.54 13.24 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.287 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.59 14.94 7.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.833 179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.445 ' HB3' ' HD3' ' A' ' 4' ' ' LYS . 39.1 tt0 61.74 -77.59 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 O-C-N 124.664 1.227 . . . . 0.0 110.436 -178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.79 39.96 1.11 Allowed Glycine 0 N--CA 1.434 -1.457 0 C-N-CA 120.45 -0.881 . . . . 0.0 113.285 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -100.04 6.89 45.03 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.802 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -72.0 -23.7 61.45 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.251 -1.795 . . . . 0.0 106.874 176.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 46.6 t -59.22 -22.82 61.65 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 114.293 -1.321 . . . . 0.0 108.862 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.75 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 1.6 t -83.4 -44.27 14.98 Favored 'General case' 0 CA--C 1.521 -0.169 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 177.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.112 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 4.0 t80 -55.94 -65.44 0.6 Allowed 'General case' 0 C--O 1.221 -0.411 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.403 177.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.852 ' SG ' ' HA ' ' A' ' 51' ' ' CYS . 49.4 t -87.67 53.81 2.91 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.431 -0.508 . . . . 0.0 111.415 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -97.65 -59.33 1.79 Allowed 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -74.48 -26.43 60.02 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.291 179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.494 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -111.49 41.88 1.8 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.447 179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.852 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 38.1 t -73.82 83.8 1.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.894 0.378 . . . . 0.0 110.258 178.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 7.0 p-80 -168.47 -170.12 1.19 Allowed 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.922 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 61.54 -101.17 0.31 Allowed Glycine 0 C--N 1.33 0.245 0 N-CA-C 114.453 0.541 . . . . 0.0 114.453 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.074 HG12 HD23 ' A' ' 29' ' ' LEU . 1.2 p -108.7 13.26 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 CA-C-O 120.807 0.337 . . . . 0.0 110.344 -178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.706 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 5.0 t -66.59 -21.39 66.13 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-O 122.054 0.931 . . . . 0.0 108.848 179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 56' ' ' LYS . 0.0 OUTLIER -78.62 -31.21 46.9 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.812 178.642 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.794 ' HB3' HG22 ' A' ' 54' ' ' VAL . 10.0 t70 -84.94 -24.41 28.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 177.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.977 HD13 HG13 ' A' ' 54' ' ' VAL . 1.1 mp -61.4 -51.99 66.47 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.301 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 84.0 m-70 84.66 65.22 0.01 OUTLIER 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.694 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -155.36 -31.75 0.1 Allowed 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 113.78 -1.554 . . . . 0.0 109.845 -175.416 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.456 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 40.9 t . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.509 -0.757 . . . . 0.0 110.031 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.243 0 CA-C-O 120.755 0.312 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 24.0 mmt -78.91 -81.17 0.11 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.23 0.538 . . . . 0.0 110.721 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.487 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . -159.33 178.32 35.52 Favored Glycine 0 CA--C 1.501 -0.834 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.567 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HE3' ' CG ' ' A' ' 40' ' ' GLU . 34.0 tttp -74.35 0.84 13.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 122.766 1.27 . . . . 0.0 107.645 177.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.53 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 99.3 m -134.19 75.47 1.59 Allowed 'General case' 0 N--CA 1.435 -1.185 0 CA-C-N 113.346 -1.752 . . . . 0.0 110.749 -177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.415 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 53.8 m -102.65 149.03 24.85 Favored 'General case' 0 C--O 1.218 -0.603 0 N-CA-C 112.913 0.708 . . . . 0.0 112.913 -178.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.727 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.4 p 40.88 -74.49 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.097 2.559 . . . . 0.0 114.524 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.727 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -87.25 -25.54 23.93 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.529 -179.331 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.503 ' CB ' ' HA ' ' A' ' 5' ' ' CYS . 28.0 mtpt -89.29 -0.69 57.66 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 177.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.652 ' HD2' ' SG ' ' A' ' 45' ' ' CYS . 24.9 mmmt -75.19 -10.02 59.08 Favored 'General case' 0 C--N 1.347 0.466 0 N-CA-C 107.918 -1.142 . . . . 0.0 107.918 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.94 -21.98 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.093 0 CA-C-N 113.676 -1.602 . . . . 0.0 108.709 179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -89.0 -10.65 46.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.295 -1.321 . . . . 0.0 113.088 -179.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.647 ' HA ' ' SG ' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -64.35 -27.37 68.97 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 120.206 -0.598 . . . . 0.0 109.891 179.794 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.55 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -69.76 -34.9 74.43 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.269 0.557 . . . . 0.0 109.59 178.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.59 -24.29 67.04 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.983 0.42 . . . . 0.0 110.89 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -98.82 -50.17 4.31 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.602 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.964 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -94.86 -36.48 6.93 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.437 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -176.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -49.71 -31.42 11.17 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 119.487 1.04 . . . . 0.0 111.173 -179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.81 -25.19 74.53 Favored Glycine 0 CA--C 1.522 0.515 0 C-N-CA 120.737 -0.744 . . . . 0.0 111.682 178.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.61 -42.33 25.15 Favored 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 122.558 0.343 . . . . 0.0 110.76 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.066 HG12 HG11 ' A' ' 32' ' ' VAL . 26.9 m -66.04 -39.22 83.92 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.758 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 178.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -59.29 -28.51 66.83 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.956 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -74.75 -26.9 60.1 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.818 179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 16.5 t -101.1 -45.84 5.26 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.89 51.35 0.08 OUTLIER Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.397 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.553 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 106.71 -177.12 21.82 Favored Glycine 0 N--CA 1.452 -0.243 0 N-CA-C 111.319 -0.713 . . . . 0.0 111.319 -179.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.937 HD13 HG11 ' A' ' 21' ' ' VAL . 19.7 mm -67.76 76.76 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 CA-C-O 122.242 1.02 . . . . 0.0 111.393 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.693 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 5.8 t0 -98.79 79.35 2.4 Favored 'General case' 0 CA--C 1.498 -1.025 0 N-CA-C 101.903 -3.369 . . . . 0.0 101.903 175.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.115 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE 0.263 0.0 OUTLIER -45.56 -40.32 13.46 Favored Pre-proline 0 N--CA 1.434 -1.269 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 -173.75 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.673 ' HB3' HG21 ' A' ' 54' ' ' VAL . 7.0 Cg_endo -75.01 -22.9 14.31 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 121.642 1.622 . . . . 0.0 111.635 176.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.5 t -82.58 -51.71 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.917 -1.038 . . . . 0.0 113.494 -178.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.066 HG11 HG12 ' A' ' 21' ' ' VAL . 0.6 OUTLIER -62.45 -33.05 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.925 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.5 OUTLIER -65.1 -11.04 35.46 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.56 -46.3 63.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.641 0.734 . . . . 0.0 109.037 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -88.91 -37.78 15.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.661 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 43' ' ' ALA . 26.8 tp -68.7 -18.74 64.31 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.745 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 3.3 mtpt -69.85 -16.78 63.31 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 117.466 -1.694 . . . . 0.0 109.857 -178.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -85.83 4.62 36.35 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.26 177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.597 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -68.76 175.17 3.73 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.125 179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' CG ' ' HE3' ' A' ' 4' ' ' LYS . 15.2 pm0 -69.72 -15.79 63.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.404 0.621 . . . . 0.0 109.644 178.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 123.93 49.11 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.647 ' SG ' ' HA ' ' A' ' 13' ' ' CYS . 13.8 t -113.63 14.78 18.93 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 121.098 0.475 . . . . 0.0 110.036 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.792 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -63.82 -27.89 69.48 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.662 178.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 48' ' ' GLU . 46.0 t -65.19 -23.19 67.03 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.727 178.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.652 ' SG ' ' HD2' ' A' ' 10' ' ' LYS . 2.5 t -86.73 -38.69 16.7 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.115 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 3.1 t80 -54.47 -66.52 0.38 Allowed 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.044 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.997 ' HB3' HD21 ' A' ' 60' ' ' LEU . 40.9 t -82.24 30.31 0.4 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 44' ' ' SER . 44.7 tt0 -87.59 -35.31 18.17 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 178.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -78.69 -44.71 22.97 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 114.688 -1.142 . . . . 0.0 109.852 178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.444 ' HE2' HD12 ' A' ' 27' ' ' ILE . 3.4 p80 -112.17 54.78 0.69 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.466 -0.788 . . . . 0.0 112.24 -179.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.831 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 54.1 t -73.1 80.46 1.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.953 0.406 . . . . 0.0 110.237 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -164.72 -169.76 1.81 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.776 -178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.51 -107.8 0.67 Allowed Glycine 0 N--CA 1.45 -0.383 0 O-C-N 123.906 0.754 . . . . 0.0 114.946 177.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.062 HG13 HD13 ' A' ' 58' ' ' LEU . 3.6 p -90.3 -0.32 8.93 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.381 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -177.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.644 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 0.6 OUTLIER -56.66 -23.94 45.09 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -71.75 -33.65 68.84 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.007 178.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -93.11 -28.07 16.56 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.732 0.777 . . . . 0.0 109.461 177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.062 HD13 HG13 ' A' ' 54' ' ' VAL . 1.0 OUTLIER -60.44 -58.21 9.48 Favored 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.331 179.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 58' ' ' LEU . 82.5 m-70 88.67 66.86 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.192 0 O-C-N 124.427 1.079 . . . . 0.0 109.969 177.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.997 HD21 ' HB3' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -153.5 -18.6 0.14 Allowed 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.34 -179.347 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.615 ' HB3' ' SG ' ' A' ' 55' ' ' CYS . 52.9 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.822 -1.085 . . . . 0.0 108.966 179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 110.384 -0.228 . . . . 0.0 110.384 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.494 ' CE ' ' HA ' ' A' ' 2' ' ' MET . 8.2 mmt 59.84 39.59 20.37 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 123.851 0.72 . . . . 0.0 110.823 -179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 107.14 -175.48 20.55 Favored Glycine 0 CA--C 1.506 -0.495 0 C-N-CA 120.299 -0.953 . . . . 0.0 111.778 -178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.599 ' HB3' ' O ' ' A' ' 42' ' ' CYS . 0.9 OUTLIER -80.56 12.14 3.28 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 177.066 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.706 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 58.5 m -133.05 113.68 13.06 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 113.395 -1.729 . . . . 0.0 110.273 -177.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.537 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 16.0 t -71.31 -171.87 0.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 120.628 0.251 . . . . 0.0 110.858 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.641 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.2 p -49.74 -59.95 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.795 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.683 HD23 ' H ' ' A' ' 8' ' ' LEU . 1.2 pt? -66.78 -27.23 67.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.981 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.537 ' HB2' ' N ' ' A' ' 6' ' ' SER . 7.9 mmtt -79.15 -6.28 56.16 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.856 0.36 . . . . 0.0 110.928 179.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 7' ' ' VAL . 11.4 mmtt -80.79 -12.56 59.42 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -102.12 -30.65 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 CA-C-N 114.074 -1.421 . . . . 0.0 107.668 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.486 ' HB3' ' HA ' ' A' ' 9' ' ' LYS . . . -83.33 -9.9 58.8 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.933 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 42' ' ' CYS . 2.6 p -70.52 -15.0 62.75 Favored 'General case' 0 CA--C 1.513 -0.457 0 C-N-CA 119.506 -0.878 . . . . 0.0 109.802 178.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.748 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -80.74 -27.27 36.88 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-O 122.073 0.939 . . . . 0.0 108.57 177.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.34 -23.47 37.75 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.485 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -94.96 -55.96 2.92 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.984 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 1.068 HG12 HD22 ' A' ' 36' ' ' LEU . 0.2 OUTLIER -96.26 -38.54 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 114.692 1.367 . . . . 0.0 114.692 -177.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.748 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -55.43 -25.4 35.87 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.562 1.074 . . . . 0.0 110.03 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -88.94 -23.0 36.71 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.551 177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 1.019 ' HB3' HD13 ' A' ' 17' ' ' ILE . . . -79.62 -41.08 27.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 120.868 0.365 . . . . 0.0 110.395 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.076 HG12 HG11 ' A' ' 32' ' ' VAL . 24.1 m -64.13 -40.51 89.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.17 -31.24 71.72 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.063 -1.426 . . . . 0.0 110.498 178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.0 -27.67 69.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.001 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.41 -46.32 5.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.209 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.13 36.51 0.22 Allowed Glycine 0 C--N 1.336 0.58 0 C-N-CA 120.524 -0.846 . . . . 0.0 112.91 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.59 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 127.58 -173.01 18.76 Favored Glycine 0 CA--C 1.511 -0.186 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.912 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.833 HD13 HG11 ' A' ' 21' ' ' VAL . 20.9 mm -72.64 75.27 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.499 1.142 . . . . 0.0 111.582 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.708 ' O ' HG13 ' A' ' 32' ' ' VAL . 36.1 t0 -103.53 79.22 1.66 Allowed 'General case' 0 CA--C 1.502 -0.877 0 N-CA-C 102.638 -3.097 . . . . 0.0 102.638 175.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.037 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 3.9 tt -44.64 -44.54 21.22 Favored Pre-proline 0 CA--C 1.548 0.866 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.981 -174.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.746 ' HB3' HG11 ' A' ' 54' ' ' VAL . 39.6 Cg_endo -68.84 -27.73 30.73 Favored 'Trans proline' 0 C--N 1.359 1.1 0 CA-C-N 120.84 1.336 . . . . 0.0 112.161 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.552 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 4.0 t -79.72 -46.25 17.41 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.689 -0.687 . . . . 0.0 112.418 -178.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.076 HG11 HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -65.24 -38.47 82.7 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -176.876 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.987 HD13 ' HG ' ' A' ' 58' ' ' LEU . 0.2 OUTLIER -76.62 10.6 2.06 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 112.952 0.723 . . . . 0.0 112.952 -177.018 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.04 -22.52 20.72 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 175.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -112.68 -35.83 5.38 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 114.046 -1.434 . . . . 0.0 109.064 178.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.068 HD22 HG12 ' A' ' 17' ' ' ILE . 21.5 tp -68.54 -22.88 64.47 Favored 'General case' 0 CA--C 1.499 -0.993 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.926 179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.652 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 7.9 tmtm? -62.82 -28.28 69.9 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.524 -1.27 . . . . 0.0 109.029 -177.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.19 18.85 3.44 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.825 178.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 36' ' ' LEU . . . -69.94 178.04 2.87 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -79.12 16.52 0.93 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.351 0.596 . . . . 0.0 110.489 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 95.6 72.77 1.15 Allowed Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.594 -0.73 . . . . 0.0 113.798 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.599 ' O ' ' HB3' ' A' ' 4' ' ' LYS . 1.5 t -134.46 -84.62 0.42 Allowed 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 177.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.914 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . 53.88 -53.08 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.392 0 N-CA-C 115.96 1.837 . . . . 0.0 115.96 176.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.709 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 43.2 t -56.19 -32.41 64.34 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 117.867 0.303 . . . . 0.0 110.594 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.706 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 7.4 t -62.31 -39.31 92.58 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 177.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.037 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 1.9 t80 -63.48 -67.3 0.44 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.106 177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.87 ' HB3' HD12 ' A' ' 60' ' ' LEU . 35.6 t -87.64 77.94 8.6 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.296 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.709 ' HG3' ' O ' ' A' ' 44' ' ' SER . 3.8 mt-10 -118.82 -56.69 2.1 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -77.74 -45.34 24.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.557 179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.508 ' ND1' HD12 ' A' ' 29' ' ' LEU . 10.0 p80 -89.89 45.15 1.25 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.185 0.517 . . . . 0.0 110.765 178.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.741 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -73.36 74.48 1.36 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.626 178.813 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -165.94 -172.75 2.42 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.981 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.48 -112.61 5.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 121.173 -0.537 . . . . 0.0 113.62 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.746 HG11 ' HB3' ' A' ' 30' ' ' PRO . 3.8 p -92.86 -1.52 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 O-C-N 122.859 -0.201 . . . . 0.0 111.021 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.718 ' HA ' HD21 ' A' ' 58' ' ' LEU . 6.2 t -60.83 -16.67 43.71 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.744 0.783 . . . . 0.0 108.953 178.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.6 tptm -76.14 -31.92 58.85 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.601 -1.181 . . . . 0.0 108.765 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -77.31 -55.69 5.2 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.598 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.987 ' HG ' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -69.0 -18.45 64.05 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.47 -179.063 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.41 ' O ' HD23 ' A' ' 60' ' ' LEU . 43.3 t60 59.81 89.29 0.07 Allowed 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 176.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.876 ' HG ' HD23 ' A' ' 58' ' ' LEU . 15.7 mt -118.46 -45.42 2.62 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.204 178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.536 -0.745 . . . . 0.0 110.921 -178.927 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 6.0 ttt -73.14 -76.77 0.11 Allowed 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . 0.553 ' C ' ' H ' ' A' ' 5' ' ' CYS . . . 92.77 -177.2 38.55 Favored Glycine 0 CA--C 1.498 -1.013 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.706 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.9 9.67 7.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 45' ' ' CYS . 3.2 m -127.59 93.03 3.61 Favored 'General case' 0 N--CA 1.43 -1.461 0 CA-C-N 112.452 -2.158 . . . . 0.0 109.905 -177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.63 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 3.3 m -61.23 -175.04 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 122.728 0.411 . . . . 0.0 111.632 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.618 HG13 ' H ' ' A' ' 8' ' ' LEU . 2.5 p -54.42 -59.39 2.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.208 0.528 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.618 ' H ' HG13 ' A' ' 7' ' ' VAL . 0.8 OUTLIER -71.36 -21.31 62.04 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.473 179.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB2' ' N ' ' A' ' 6' ' ' SER . 40.5 mttp -81.69 -16.63 50.65 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.013 179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.884 ' HA ' ' SG ' ' A' ' 13' ' ' CYS . 7.4 ptmm? -75.67 -9.85 58.94 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.66 0.743 . . . . 0.0 109.341 -179.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -88.2 -25.25 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 114.458 -1.246 . . . . 0.0 107.722 177.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -88.0 -8.21 55.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.125 -1.398 . . . . 0.0 111.713 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.884 ' SG ' ' HA ' ' A' ' 10' ' ' LYS . 3.9 m -66.06 -19.08 65.73 Favored 'General case' 0 C--O 1.214 -0.809 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -67.27 -36.37 81.44 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.192 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.78 -28.47 69.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.171 0.51 . . . . 0.0 110.301 178.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -92.34 -51.34 5.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.558 -0.746 . . . . 0.0 112.283 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.99 HD11 HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -97.32 -41.68 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -52.92 -29.1 26.6 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.42 1.009 . . . . 0.0 110.358 -179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -72.37 -29.57 65.98 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.339 -0.934 . . . . 0.0 110.895 177.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.02 -37.1 58.78 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 122.362 0.265 . . . . 0.0 111.004 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.0 HG12 HG11 ' A' ' 32' ' ' VAL . 23.2 m -69.42 -39.47 78.76 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.708 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -56.78 -28.8 61.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.208 -1.36 . . . . 0.0 109.872 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.63 -30.15 71.16 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.954 178.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.88 -59.87 1.66 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.506 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.63 -41.83 0.11 Allowed Glycine 0 CA--C 1.525 0.678 0 C-N-CA 120.258 -0.972 . . . . 0.0 113.878 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 170.41 102.14 0.15 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.405 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.766 HD13 HG11 ' A' ' 21' ' ' VAL . 25.7 mm 46.31 52.04 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 122.908 1.337 . . . . 0.0 112.783 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.543 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.8 OUTLIER -91.42 75.31 6.0 Favored 'General case' 0 N--CA 1.436 -1.155 0 N-CA-C 102.856 -3.016 . . . . 0.0 102.856 174.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.988 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 1.5 pt? -40.38 -43.4 3.8 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -173.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.688 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 40.3 Cg_endo -70.32 -19.94 32.8 Favored 'Trans proline' 0 C--N 1.358 1.078 0 CA-C-N 121.339 1.514 . . . . 0.0 112.336 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.519 ' HB3' ' HB2' ' A' ' 28' ' ' ASP . 8.6 t -90.48 -49.27 6.6 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.648 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.0 HG11 HG12 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -61.14 -32.82 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 116.605 -0.27 . . . . 0.0 110.641 -179.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.96 HD22 ' HG ' ' A' ' 58' ' ' LEU . 0.3 OUTLIER -71.77 5.92 2.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 112.068 0.395 . . . . 0.0 112.068 -179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -36.44 13.86 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 177.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -97.35 -38.48 9.63 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.851 -1.068 . . . . 0.0 109.808 178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.8 HD22 ' CG1' ' A' ' 17' ' ' ILE . 26.8 tp -71.5 -17.69 62.33 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.382 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 33' ' ' LEU . 39.6 ttmt -60.23 -20.13 57.5 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 119.067 -1.053 . . . . 0.0 112.061 -176.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.19 -12.21 61.47 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -107.23 53.66 0.69 Allowed 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.779 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -65.21 88.93 0.08 Allowed 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 159.85 -30.19 0.39 Allowed Glycine 0 N--CA 1.433 -1.522 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.885 -178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.43 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 0.1 OUTLIER -112.31 5.37 18.24 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 118.41 1.105 . . . . 0.0 108.32 178.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.845 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -71.11 -32.28 68.82 Favored 'General case' 0 N--CA 1.439 -0.998 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.731 ' O ' ' HB3' ' A' ' 48' ' ' GLU . 14.6 m -62.07 -19.89 63.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.831 176.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.69 ' HB2' ' SG ' ' A' ' 5' ' ' CYS . 45.7 t -82.97 -37.76 23.63 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 177.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.988 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 7.8 t80 -62.6 -70.63 0.19 Allowed 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 113.163 -1.835 . . . . 0.0 110.787 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 2.9 t -84.12 12.75 5.94 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.731 ' HB3' ' O ' ' A' ' 44' ' ' SER . 3.7 pt-20 -64.14 -36.68 84.84 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 120.341 1.428 . . . . 0.0 112.588 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.455 ' HB3' ' HD2' ' A' ' 50' ' ' HIS . 37.5 t70 -88.56 -14.47 37.56 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.351 0.595 . . . . 0.0 110.802 -178.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.529 ' CD2' ' N ' ' A' ' 50' ' ' HIS . 0.0 OUTLIER -128.28 40.5 3.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.381 -178.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.672 ' HA ' ' SG ' ' A' ' 55' ' ' CYS . 1.3 m -73.86 59.61 0.69 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.503 0.668 . . . . 0.0 110.711 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.17 -176.07 4.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.655 -179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 59.45 -107.21 1.16 Allowed Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.708 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 1.099 HG13 HD13 ' A' ' 58' ' ' LEU . 1.4 p -92.88 -3.33 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 122.598 -0.354 . . . . 0.0 111.177 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 58' ' ' LEU . 1.9 t -61.1 -18.92 60.51 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -78.59 -33.98 47.13 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.42 ' HB3' HG22 ' A' ' 54' ' ' VAL . 1.1 t70 -79.86 -32.12 40.47 Favored 'General case' 0 CA--C 1.519 -0.239 0 N-CA-C 107.567 -1.272 . . . . 0.0 107.567 177.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.099 HD13 HG13 ' A' ' 54' ' ' VAL . 1.4 mp -58.85 -57.99 10.59 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 113.39 -1.732 . . . . 0.0 107.488 178.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.2 t60 68.09 72.23 0.31 Allowed 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.091 -0.958 . . . . 0.0 108.593 178.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.845 HD12 ' HB1' ' A' ' 43' ' ' ALA . 0.0 OUTLIER -135.71 -14.12 1.91 Allowed 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 113.89 -1.505 . . . . 0.0 110.179 -176.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.467 ' N ' HD23 ' A' ' 60' ' ' LEU . 28.0 p . . . . . 0 C--O 1.245 0.853 0 CA-C-O 118.183 -0.913 . . . . 0.0 109.659 178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 120.799 0.333 . . . . 0.0 110.727 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 50.4 ttm -77.47 -70.94 0.44 Allowed 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 72.14 -158.64 53.43 Favored Glycine 0 CA--C 1.499 -0.931 0 C-N-CA 120.215 -0.993 . . . . 0.0 112.899 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.5 tppm? -65.09 -21.5 66.82 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 122.488 1.137 . . . . 0.0 108.019 177.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.674 ' SG ' ' HB3' ' A' ' 13' ' ' CYS . 1.6 m -80.95 75.47 7.92 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.171 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.674 ' N ' ' HB2' ' A' ' 9' ' ' LYS . 7.1 m -65.46 -166.47 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 110.15 -0.315 . . . . 0.0 110.15 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.616 HG13 ' H ' ' A' ' 8' ' ' LEU . 1.6 p -52.34 -59.01 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.938 0.399 . . . . 0.0 111.771 179.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.616 ' H ' HG13 ' A' ' 7' ' ' VAL . 2.6 pt? -78.31 -24.52 46.62 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.066 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.674 ' HB2' ' N ' ' A' ' 6' ' ' SER . 21.1 mmmt -81.59 -12.41 58.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 120.883 0.373 . . . . 0.0 110.281 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.413 ' HB2' ' O ' ' A' ' 6' ' ' SER . 23.3 ttmm -76.82 -14.61 59.89 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-O 121.659 0.742 . . . . 0.0 109.13 179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.57 -24.41 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.842 0 CA-C-O 121.976 0.893 . . . . 0.0 108.671 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -85.75 -10.28 55.82 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 114.26 -1.337 . . . . 0.0 113.437 -178.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' HB3' ' SG ' ' A' ' 5' ' ' CYS . 16.5 p -69.12 -23.86 64.04 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 119.451 -0.9 . . . . 0.0 109.744 179.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.726 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -76.71 -29.66 56.35 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-O 121.395 0.617 . . . . 0.0 109.55 178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.95 -24.23 44.05 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-O 121.241 0.543 . . . . 0.0 109.914 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -91.5 -53.88 4.13 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.151 -0.932 . . . . 0.0 112.535 -179.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.956 HG12 HD22 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -91.72 -34.98 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -177.407 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.726 ' HB3' ' O ' ' A' ' 14' ' ' ALA . . . -61.15 -21.62 63.93 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 119.458 1.027 . . . . 0.0 108.914 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -86.47 -33.64 13.4 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.85 177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB3' ' CD1' ' A' ' 17' ' ' ILE . . . -77.07 -38.55 52.29 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 117.263 0.531 . . . . 0.0 110.581 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 1.071 HG12 HG11 ' A' ' 32' ' ' VAL . 18.6 m -63.4 -39.74 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 178.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.57 -32.11 71.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 113.935 -1.484 . . . . 0.0 110.896 178.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.68 -22.48 62.47 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 121.067 0.461 . . . . 0.0 110.262 179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 34.3 t -98.71 -40.8 7.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.516 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 140.9 -20.72 2.69 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.379 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.46 ' O ' ' HB ' ' A' ' 21' ' ' VAL . . . 174.84 -165.67 37.01 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.707 HD13 HG11 ' A' ' 21' ' ' VAL . 9.4 mm -73.4 87.48 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 122.461 1.124 . . . . 0.0 111.221 179.566 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.643 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 11.4 t70 -116.37 88.65 2.94 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 103.752 -2.684 . . . . 0.0 103.752 176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 1.036 ' HA ' ' HZ ' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -45.83 -43.13 27.52 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 -174.413 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.605 ' HD3' ' HG ' ' A' ' 29' ' ' LEU . 61.3 Cg_endo -74.17 -20.59 18.8 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 121.471 1.561 . . . . 0.0 111.828 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 6.2 t -83.73 -50.24 8.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.642 -178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 1.071 HG11 HG12 ' A' ' 21' ' ' VAL . 1.1 m -66.26 -34.62 71.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.927 HD11 HD11 ' A' ' 60' ' ' LEU . 6.7 mt -81.17 30.35 0.33 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.16 -35.37 8.92 Favored 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 105.63 -1.989 . . . . 0.0 105.63 175.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.81 -35.99 7.17 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 113.886 -1.506 . . . . 0.0 109.122 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.956 HD22 HG12 ' A' ' 17' ' ' ILE . 23.8 tp -68.1 -20.15 64.91 Favored 'General case' 0 CA--C 1.502 -0.874 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.611 178.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.576 ' HD3' HD22 ' A' ' 33' ' ' LEU . 16.5 tptm -61.03 -17.74 53.98 Favored 'General case' 0 C--N 1.312 -1.022 0 C-N-CA 119.317 -0.953 . . . . 0.0 110.548 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -68.78 -24.8 64.47 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.74 70.85 4.17 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 177.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -40.42 92.82 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 O-C-N 124.559 1.162 . . . . 0.0 113.498 -177.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.8 23.93 68.41 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 115.508 0.963 . . . . 0.0 115.508 177.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -111.26 2.12 17.54 Favored 'General case' 0 CA--C 1.491 -1.292 0 CA-C-N 119.882 1.841 . . . . 0.0 107.098 176.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.633 ' HA ' HD21 ' A' ' 36' ' ' LEU . . . -75.46 -15.78 60.39 Favored 'General case' 0 N--CA 1.429 -1.522 0 CA-C-N 112.035 -2.348 . . . . 0.0 105.641 174.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.493 ' O ' ' HG3' ' A' ' 48' ' ' GLU . 30.5 t -61.2 -25.23 66.9 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 112.716 -2.038 . . . . 0.0 108.673 177.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 22.2 t -82.93 -37.75 23.72 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.974 0.893 . . . . 0.0 108.74 177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 1.036 ' HZ ' ' HA ' ' A' ' 29' ' ' LEU . 14.3 t80 -60.19 -64.75 0.84 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.1 -1.409 . . . . 0.0 110.719 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.886 ' HB2' HD12 ' A' ' 60' ' ' LEU . 49.1 t -67.58 6.73 0.58 Allowed 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 44' ' ' SER . 28.0 mt-10 -59.81 -47.06 87.25 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.971 -1.081 . . . . 0.0 111.773 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -75.79 -33.87 60.17 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.713 ' CE1' ' HA ' ' A' ' 47' ' ' CYS . 6.5 p80 -119.16 64.19 0.79 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.691 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.9 t -80.73 75.22 7.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.306 178.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -170.71 -174.34 1.57 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.173 -178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 57.37 -114.95 6.01 Favored Glycine 0 N--CA 1.451 -0.304 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.393 177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.64 ' O ' HD13 ' A' ' 58' ' ' LEU . 5.4 p -86.24 -0.08 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.783 0 CA-C-N 115.594 -0.303 . . . . 0.0 111.621 -178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . 0.66 ' HA ' HD21 ' A' ' 58' ' ' LEU . 36.1 t -65.93 -15.86 63.35 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 122.007 0.908 . . . . 0.0 108.821 178.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 6.1 tttm -79.87 -23.05 42.17 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.507 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.92 -49.93 6.76 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.793 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.036 HD23 ' HG ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -70.44 -10.23 58.58 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 120.109 -0.636 . . . . 0.0 111.652 -179.685 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.573 ' O ' HD23 ' A' ' 60' ' ' LEU . 57.6 m170 68.45 72.83 0.29 Allowed 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 115.045 1.498 . . . . 0.0 115.045 176.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 1.036 ' HG ' HD23 ' A' ' 58' ' ' LEU . 24.7 mt -127.39 -65.7 0.92 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 121.453 0.644 . . . . 0.0 110.471 177.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 40.3 t . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.191 -178.993 . . . . . . . . 0 0 . 1 stop_ save_